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CHAPTER I 
INTRODUCTION 
The parabrachial nucleus (PB), located in the pontine region of 
the brainstem, has historically been associated with taste and feeding. 
Recently, physiological studies have implicated the PB in a number of 
other visceral/autonomic functions, including: pain, bladder control, 
thirst, and cardiovascular and respiratory responses. Anatomical 
studies have demonstrated that the PB is extensively connected with 
autonomic nuclei in both the forebrain and lower brainstem. Based on 
these responses and connections, investigators have proposed a pivotal 
role for the PB in the central regulation of autonomic function. 
Like other central autonomic nuclei, the PB contains a high 
density of neuropeptide-immunoreactive cells and fibers. Hicro-
injections of neuropeptides into autonomic nuclei, such as the PB, 
produce a variety of visceral effects. Possibly the neuropeptides 
present in the PB may be important in mediating its visceral responses, 
As a first step to understanding the role of neuropeptides in the PB, 
this dissertation sought to determine the sources of peptidergic input 
to the PB using the combined retrograde tracer-immunohistochemical 
method. 
As the number of neuropeptides and the number of PB pathways is 
quite large, the scope of this dissertation is limited to an 
examination of the neuropeptides in forebrain afferents of the PB. The 
1 
2 
peptidergic content of these afferents is almost entirely unknown. 
Furthermore, these forebrain projections to the PB and their intrinsic 
neuropeptides have been implicated in the control of visceral 
functions, such as respiratory and cardiovascular responses (e.g., 
Harper et al., '84). 
The PB receives input from four major areas in the forebrain: the 
central nucleus of the amygdala (CeA), the bed nucleus of the stria 
terminalis (BST), the hypothalamus and the cortex. All of these areas 
contain neuropeptide-like immunoreactlve cells and fibers. However, in 
preliminary experiments, neuropeptide-immunoreactive cells in the 
cortex were not found to contribute to the cortical-PB pathway. Many 
of the immunoreactive neurons in the insular and infralimbic cortices 
did not have the appearance of pyramidal cells (i.e., PB projecting 
cells); these cells may instead represent local projection neurons. 
Thus, this dissertation specifically examines, in three series of 
experiments, the peptidergic pathways from the CeA, BST and hypo-
thalamus to the PB. In all experiments, the combined retrograde 
fluorescence-immunofluorescence method was used (Sawchenko and Swanson, 
1 81). 
Antisera to the neuropeptides were chosen based on the following 
criteria: one, the abundance of the antisera-stained cells in the 
nucleus projecting to the PB; two, the staining quality of the 
antisera; and three, the presence of antisera-stained fibers in the PB. 
Neuropeptides previously described in a forebrain pathway to the PB 
were not re-examined. As a control for antisera specificity, antisera 
were preincubated with their respective, synthetic neuropeptides, and 
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the sections processed as usual to determine whether any residual 
staining remained. Although immunohistochemical staining was 
eliminated in these controls, it is possible that these antisera may 
recognize unidentified neuropeptides containing similar amino acid 
sequences. Therefore, the neuropeptide immunoreactivity described in 
the following experiments is more accurately described as neuropeptide-
like immunoreactivity (-ir), reflecting our uncertainty as to the 
precise targets of the antisera. 
In the first series of experiments (Chapter Ill), neurons in the 
central nucleus of the amygdala that project to the PB were examined 
for their peptide content using antisera to the neuropeptides, 
corticotropin releasing factor (CRF), neurotensin (NT), somatostatin 
(SS) and proenkephalin (ENI<). These antisera were chosen because 
neurons which stain for these antisera are particularly numerous in the 
CeA. Substance P-like immunoreactive neurons are also abundant in the 
CeA but their contribution to the CeA-PB pathway has been previously 
reported (Milner and Pickel, t86b). 
In the second series of experiments (Chapter IV), neurons in the 
bed nucleus of the stria terminalis that project to the PB were 
examined for their peptide content. The BST and CeA are considered by 
some investigators to be one anatomical entity (e.g., DeOlmos et al., 
1 85). To compare the peptidergic projections of the BST and CeA, I 
used similar antisera in both experiments. Like the CeA, CRF-ir, 
NT-ir, SS-ir and ENK-ir neurons are the most numerous of the 
neuropeptide-like immunoreactive neurons in areas of the BST which 
project to the PB. 
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In the third series of experiments (Chapter V), I examined the 
projection from the hypothalamus to the PB for its peptide content 
using antisera to a wide variety of neuropeptides: CRF, NT, SS, 
dynorphin, met-enkephalin, oxytocin, vasopressin, angiotensin II, 
galanin, alpha-melanocyte stimulating hormone, and adrenal cortico-
tropin hormone. Thia large number of antisera waa used in the hopes of 
finding a "major" (i.e., predominant) putative neurotransmitter in the 
hypothalamic projection to the PB, and also, of determining any 
differences in the peptidergic projections from different hypothalamic 
nuclei. 
Modifications to the combined retrograde fluorescence-
immunofluorescence technique were made during the course of these 
experiments. Preincubation with either Triton-X and/or normal goat 
serum prior to the incubation with the primary antibody was found not 
to be necessary and so, was excluded in the later experiments. Early 
experiments used a rhodamine-conjugated secondary antibody, whereas 
later experiments used a biotinylated secondary antibody followed by 
Texas Red-conjugated avidin. This was done for two reasons: one, 
subsequent lots of the rhodamine-conjugated antibody were not as 
brightly staining or as reliable, and the avidin-biotin-Texas Red 
complex produced a consistent, brightly-stained material which was more 
resistant to fading. In addition, the anesthetic was changed from 
sodium pentobarbital to chloral hydrate because increments of chloral 
hydrate could be added as needed with little risk to the survival of 
the animal. Fluoro-gold, a retrograde fluorescent tracer, became 
available during the course of these experiments and was used in a few 
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animals. During the BST and hypothalamus experiments, a fluorescent 
plotting system became available. With this system, multiple, actual 
sections could be and were easily plotted. 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
Historical perspective. A structure hoaologous to the 
parabrachial nucleus in mammals was first described in cyprinoid and 
siluroid fishes by Herrick ('05). He termed this homologous structure 
the superior secondary gustatory nucleus (SSGN), thus recognizing its 
importance in the central gustatory pathways. In cyprinoids and 
siluroids, the central gustatory pathways are particularly well 
developed and yet, are uncomplicated by the development of other 
systems; hence, they provide a model for the study of the gustatory 
pathways, and in particular the parabrachial nucleus, in higher 
vertebrates. In the fish, Herrick ('05) found that gustatory afferents 
reach the brain over the facial, glossopharyngeal and vagus nerves and 
that these afferents terminate in the nucleus of the solitary tract 
(NTS). From the NTS, secondary gustatory fibers ascend ipsilaterally 
to the SSGN in the dorsal isthmus region. The SSGN in fish is a 
circular structure encapsulated by a dense layer of heavily myelinated 
fibers passing downward from the cerebellum, and shows little intrinsic 
organization. Herrick ('05) noted two types of cells within the SSGN: 
the 'intrinsic' neuron, located in the center of SSGN and projecting to 
the contralateral SSGN; and the tertiary gustatory neuron, located 
along the perimeter of SSGN and projecting to the ventral diencephalon. 
6 
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This pattern of gustatory connections (i.e., periphery to NTS to 
sSGN/PB to ventral diencephalon) is apparently maintained in amphibians 
and reptiles (Barnard, '36; Herrick, '44, '48). Early studies in 
mammals (Allen, '23; Barnard, '36) were unsuccessful in detecting 
similar gustatory pathways. Using the Marchi degeneration method 
after lesions of the NTS and/or neighboring nuclei gracilis and 
cuneatus in the guinea pig, Allen ('23) noted degenerating fibers 
coursing ventromedially in an arc to the medial lemniscus of the 
opposite side. These degenerating fibers were seen to terminate in the 
ventral portion of the dorsal thalamus. Similarly in the mouse, 
Barnard ('36) also noted fibers solely in the medial lemniscus after 
NTS lesions. Furthermore, he could find no evidence for a secondary 
visceral or gustatory nucleus. He supposed that the reduction in a 
synapse in the central gustatory pathways in mammals was due to 'the 
general process of greater cephalization'. Consequently, for over half 
a century, it was assumed that in mammals secondary gustatory fibers 
ascended with somatic fibers in the medial lemniscus to the thalamic 
'taste area' (Ranson, '36; Zeman and Innes, '63; Burton and Benjamin, 
'71). 
Beginning in 1971, Norgren and his colleagues reevaluated the 
central gustatory pathways in mammals using a more sensitive antero-
grade degeneration technique. After lesions in the rostral NTS, Norgen 
and Leonard ('71) found a concentration of degenerating fibers in the 
pontine tegmentum surrounding the superior cerebellar peduncle. 
Electrical recording from neurons in this area demonstrated that they 
receive gustatory input from both the anterior and posterior portions 
8 
of the tongue (Norgren and Ffaffmann, '75). Lesions of this 'pontine 
taste area' produced degenerating fibers in the previously identified 
lingual-taste area in the ventrobasal thalamus (Norgren and Leonard, 
•71). Later studies, using the tracers horseradish peroxidase (HRP) 
and tritiated amino acids, showed that neurons in PB project not only 
to the taste area of the thalamus but also to the caudal lateral 
hypothalamus, substantia innominata, central nucleus of the amygdala 
and bed nucleus of the stria terminalis (Norgren and Leonard, '73; 
Norgren, 1 74; Norgren, '76; Saper and Loewy, '80). Furthermore, 
physiological studies have found that many of these PB projections to 
the forebrain contain gustatory information (Norgren, '74,'76). From 
these studies, the central organization of the mammalian gustatory 
system was found to closely resemble the gustatory system first 
described by Herrick in the fish. 
Anatomical relations. A number of anatomical studies of the 
mammalian PB followed the work of Norgren and his colleagues. In the 
rat, the parabrachial nucleus (PB) surrounds the superior cerebellar 
peduncle (scp) in the dorsolateral pons. Traditionally, the PB has 
been divided into medial and lateral subdivisions; these are, 
respectively, medial and lateral to the scp (Seper and Loewy, '80). 
Rostrally, neurons in the PB first appear dorsal and lateral to the scp 
and caudal to the main body of the pedunculopontine nucleus. Rostral 
PB is bordered dorsally by the cuneiform nucleus, laterally by the 
lateral lemniscus, and ventrally by the pontine reticular formation. 
The medial border of rostral PB includes the central gray, the 
dorsolateral tegmental nucleus, and the mesencephalic tract and nucleus 
of the trigeminal nerve (Mess}. 
The caudal half of PB begins as the inferior colliculus separates 
from the dorsal pons. Caudal PB is bordered dorsally and laterally by 
the ventral spinocerebellar tract, ventrally by the aupratrigeminal 
nucleus and pontine reticular formation, and medially by Mess and the 
trochlear nerve. Caudal PB is also in close proximity to the fourth 
ventricle, the locus coeruleus and the motor nucleus of the trigeminal 
nerve. PB is replaced caudally by the vestibular nuclei. 
The Kolliker-Fuse nucleus (KF}, situated ventral and lateral to 
the main body of the PB, is also considered to be a part of the 
parabrachial nucleus (Saper and Loewy, '80; Fulwiler and Saper, '84). 
KF is bordered medially by the supratrigeminal nucleus, ventrally by 
the principal sensory nucleus of the trigeminal nerve, and laterally by 
the middle cerebellar peduncle. 
Cytoarchitecture. In a study of PB cytoarchitecture in the rat, 
Fulwiler and Saper ('84) demonstrated that the PB is composed of ten 
cytologically distinct subnuclei. These subnuclei reside within the 
boundaries of the lateral, medial and Kolliker-Fuse subdivisions (Fig. 
1). Lateral PB contains several homogenous groups of cells which may 
be distinguished by their morphology, spatial clustering, or a 
combination of both. Rostrally, the superior lateral subnucleus (sl) 
appears as a prominent, triangular cluster of darkly-staining, 
multipolar cells. The extreme lateral subnucleus (exl}, a relatively 
small cell group, indents the medial border of the lateral lemniscus. 
Cells in exl have similar staining characteristics to those in sl. The 
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internal lateral subnucleus (il), located at mid-PB levels, is a 
distinctive round cluster of large, round cells. The external lateral 
aubnucleus (el), contains medium-sized, densely packed cells, and is 
unique among PB subnuclei for its metachromatic staining. The central 
lateral subnucleus (cl) occupies most of the area dorsal to the scp in 
the rostral two-thirds of PB. Cells in cl are ovoid to fusiform in 
shape and stain less darkly than cells in other subnuclei. Along the 
ventral and dorsal aspects of cl, two clusters of neurons can be 
identified which are similar in appearance to cl cells but have a 
greater packing density. These clusters are: the ventral lateral 
subnucleus (vl), which lies dorsal to the narrow portion of the scp, 
and the dorsal lateral subnucleus (dl), which is located ventral to the 
spinocerebellar tract. 
Medial PB contains two subnuclei. The medial subnucleus (med) is 
composed of a heterogenous population of neurons. Three cell types, 
based on cell size and morphology, have been identified in the medial 
subnucleus. These include: large, fusiform or multipolar neurons in 
the caudal two-thirds of med, medium-sized, polygonal cells in rostral 
med, and small, round neurons in caudalmost med. The extreme medial 
subnucleus (exm) is distinguished by its homogenous cluster of large, 
multipolar neurons which lie ventral to the lateral part of the scp. 
The Kolliker-Fuse subnucleus (KF), located ventral and lateral to the 
superior cerebellar peduncle (scp), consists of medium- to large-sized, 
pyramidal shaped neurons with distinct nucleoli. 
Two additional areas within the PB are defined: the 'waist' area, 
which includes the caudal portions of the vl and med subnuclei, and the 
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•cap' area, which encircles the lateral border of the scp a~d consists 
of med, el and possibly, KF (Fulwiler and Saper, '84). These areas are 
not cytologically distinct but are useful when describing patterns of 
labeling seen after injections into, for example, the central nucleus 
of the amygdala or the substantia innominata. 
Efferent Conections. The efferent connections of the parabrachial 
nucleus have been well characterized (for review, Saper and Loewy, '80; 
Fulwiler and Saper, '84). The PB projects extensively to visceral-
related nuclei in the cortex, amygdala, hypothalamus, thalamus and 
brainstem (Table 1). Each PB efferent projection arises from a 
characteristic subnuclear population composed of one or more subnuclei 
(Fulwiler and Saper, 1 84). Briefly, the PB projection to the cortex 
(i.e., insular and infralimbic) arises predominantly from the medial 
and external medial subnuclei. Projections to the amygdala are 
restricted to the external lateral subnucleus and waist area. The 
hypothalamus receives input from the superior lateral, central lateral, 
extreme lateral and dorsal lateral subnuclei. PB projections to the 
brainstem originate largely from the Kolliker Fuse nucleus. And the PB 
thalamic projection arises primarily from the internal lateral, medial, 
external medial and central lateral subnuclei. 
Afferent Connections. The parabrachial nucleus also receives 
dense input from many of the same autonomic nuclei to which it sends a 
projection (Table 2). Parabrachial afferents may display a subnuclear 
topography in their terminations but this has been incompletely 
studied. In an early study, Norgren ('78) noted some degree of 
topography in the NTS projection to the PB; he found that the rostral 
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NTS innervates primarily the medial part of the PB and that the cau<laJ 
NTS projects mainly to the lateral PB. The cortical projection to the 
pB also appears to be topographically organized (Saper, 1 82). 
Injections into the dorsal part of the insular cortex produce 
anterograde labeling in the ventral and medial parts of the PB whereas 
injections into the ventral insular cortex produce more widespread 
labeling, including the area of the PB dorsally adjacent to the 
superior cerebellar peduncle. In addition, the hypothalamic and 
amygdalar afferents may also terminate in discrete areas of the PB 
(Moga et al., '86). 
Immunocytochemistry. Like other visceral-autonomic nuclei, the 
parabrachial nucleus contains many different types of neuropeptide-like 
immunoreactive cells and fibers, each of which exhibits its own 
characteristic distribution within the PB (Block and Hoffman, '87). A 
nwnber of pathways associated with these peptidergic cells and fibers 
have been identified (Table 3). For example, neurons that project 
from the NTS to the PB stain for neurotensin-, somatostatin-, substance 
P-, cholecystokinin-, galanin-, corticotropin releasing factor-, 
angiotensin II-, and neuropeptide Y- immunoreactivity (Hantyh and 
Hunt, '84; Milner and Pickel, '86a,b; Herbert et al., '87). The PB 
neurons that project to the amygdala contain neurotensin-, enkephalin-, 
substance P-, and calcitonin gene related peptide-immunoreactivity 
(Block et al., '83; Shimada et al., '85; Zardetto-Smith and Gray, 1 86). 
The peptide content of descending pathways (i.e., from cortex, 
hypothalamus and amygdala) to the PB is largely unknown. Thus far, a 
small number of substance P-immunoreactive (SP-ir) neurons in the 
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central nucleus of the amygdala have been found to project to the PB 
(Milner and Pickel, '86a). The PB also receives SP-ir and neurotensin-
immunoreactive input from the hypothalamus, particularly from the 
perifornical area of the lateral hypothalamus (Milner and Pickel, 
'86a,b). Neurophysin II (i.e., oxytocin) containing fibers in the PB 
probably arise from the paraventriuclar hypothalamus (Swanson, '77). 
Role in Respiration. Early physiological studies of the 
parabracbial nucleus focused on its role in respiration. Based on his 
lesions of the brainstem at different levels, Lumsden ('23) postulated 
that the upper part of the pons contained a 'pneumotaxic centre', a 
center which could inhibit the activity of the lower apneustic centers, 
and thus, was important in the generation of normal respiratory rhythm. 
The first direct evidence for the existence of this pneumotaxic center 
was given by Cohen and Wang ('59) who recorded unit discharges 
phase-locked to respiration in the general region of the PB. Three 
sets of respiratory neurons were consequently noted in the PB and the 
neighboring Kolliker-Fuse nucleus: expiratory, located medially; 
inspiratory, recorded laterally; and phase spanning inspiratory-
expiratory, found between them (Bertrand and Hugelin, '71). 
Anesthetized animals that have bilateral lesions of the PB exhibit 
a slow, deep pattern of breathing (Bertrand and Hugelin, '71; von Euler 
et al., '76). With bilateral vagotomy, the pattern of breathing 
becomes apneustic (inspiratory gasping). Chronic vagotomized 
preparations with PB lesions which breathe apneustically when 
anesthetized, eventually return to a slow, deep pattern of breathing 
when awake (St. John et al., '72). Thus, the PB does not appear to be 
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a primary source of respiratory rhythm generation. However, electrical 
stimulation of the PB region can cause a premature termination of the 
current respiratory phase (Feldman and Gautier, '76; von Euler and 
Trippenbach, '76; Cohen, '71). Thus, the role of the PB in respiration 
may be to 'finely tune the pattern generator' (Mitchell and Berger, 
'81). 
Cardiovascular Regulation. In several early surveys of the 
brainstem, a marked rise in blood pressure and/or an increase in heart 
rate was noted following electrical stimulation of the dorsolateral 
pons (Wang and Ranson, '39; Chai and Wang, '62; Coote et al., '73). 
Nuclei implicated in this pressor response included the PB, locus 
coeruleus, fastigial nucleus of the cerebellum (via its fibers in the 
brachium conjunctivum) and reticular formation (e.g., Miura and Reis, 
'69; Ward and Gunn, '76). Subsequent anatomical studies noted that the 
PB was extensively connected with nuclei involved in cardiovascular 
regulation (for review, Saper, '78; Loewy and McKellar, '79). Recent 
physiological studies have provided strong evidence that the PB is 
important in cardiovascular regulation (Mraovitch et al., '82; Galeno 
and Brody, '83; Cechetto and Calaresu, '83). 
Electrical stimulation restricted to the PB in the rat and cat 
elicits a profound pressor response consisting of tachycardia, elevated 
mean arterial pressure, renal and mesenteric vasoconstriction, and 
vasodilation in skeletal muscle (Mraovitch et al., '82; Galeno and 
Brody, '83). This pressor response persists after acute midbrain 
hemisections or bilateral NTS lesions, indicating that it is intrinsic 
to PB neurons (Mraovitch et al., '82). Furthermore, many neurons in the 
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pB respond to either carotid sinus and/or aortic depressor nerve 
stimulation, demonstrating that the PB receives baroreceptor and 
chemoreceptor input (Cechetto and Calaresu, '83). This input may be 
the source of the cardiac cycle related discharge of PB neurons (Sieck 
and Harper, '80a). 
In the rat, the PB is one of a few nuclei projecting to the 
cardiomotor neurons in the nucleus ambiguus (Stuesse and Fish, '84). 
As the nucleus ambiguus forms the vagal efferent limb of the 
baroreceptor reflex, the PB may be an important modulator of this 
reflex. Following concurrent stimulation of the carotid sinus nerve 
(CSN) and the PB, the decrease in arterial pressure and bradycardia 
characteristic of the baroreceptor reflex is abolished, indicating an 
inhibitory interaction between the PB and baroreceptor mechanisms of 
the CSN (Mraovitch et al., 1 82). Recently, Hubbard et al. ('87) found 
that rats with bilateral lesions of the PB show an increased baroreflex 
sensitivity following injections of phenylephrine. 
Sleep. Cardiovascular- and respiratory-related neurons in the PB 
show changes in firing rate and pattern during the sleep-wake cycle 
(Sieck and Harper, 'SOa,b). The firing of medial PB neurons in phase 
with the cardiac cycle is most apparent during the awake and 
desynchronized sleep states, and is greatly reduced or absent during 
synchronized sleep. Changes in the firing of respiratory-related PB 
neurons parallels the variations in respiratory patterns associated 
with the different sleep-wake states. For example, high neuronal 
discharge rates with marked variability are found in the medial PB 
during desynchronized sleep, a sleep state which can be characterized 
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by its fast, irregular breathing pattern. In contrast, during 
9ynchronized sleep, PB neurons show a slow rate of discharge consistent 
with the slower rate of breathing found during this state. Sieck and 
Harper ('80b) suggest that the correlations between PB neuronal 
discharge and sleep-wake state may be a result of, or contribute to, 
the different control of autonomic functions during the sleep-wake 
cycle. 
Nociception. Bilateral lesions of the caudal, medial PB do not 
alter nociceptive thresholds as assessed by the tail flick and hot 
plate assays (Hammond and Proudfit, '80). However, these lesions do 
attentuate the analgesia induced by morphine, suggesting that the PB 
may be involved in the expression of morphine analgesia. The PB 
contains a high density of opiate receptors (Atweh and Kuhar, '77), and 
a high concentration of opioid-immunoreactive cells and terminals 
(Williams and Dockray, '83). Furthermore, the PB is reciprocally 
connected with the dorsal raphe nucleus and the periaqueductal gray 
matter (Sakai et al., '77; Beitz, '82a; unpublished observations). 
Numerous studies have demonstrated the involvement of these nuclei in 
the mediation of morphine analgesia (for review, Mayer and Price, '76; 
Fields and Basbaum, '78). Thus, the PB may also be an integral part of 
the brainstem mechanisms mediating opiate analgesia. 
Electrical stimulation of the PB inhibits the responses of upper 
thoracic spinothalamic neurons to somatic input (Girardot et al., '87) 
and to cardiopulmonary sympathetic afferent input, particularly the 
C-fiber component (Brennan et al., '87). As the spinothalamic tract is 
involved in the transmission of nociceptive information, these studies 
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suggest that the PB may be an important modulator of nociception at the 
spinal level. 
Recently, the PB was found to receive input from the large, 
flattened neurons in lamina I of the spinal cord (Cechetto et al., 
'85). Many of these neurons projecting to the PB stain for the 
opioids, met-enkephalin and dynorphin (Standaert et al., '86). These 
lamina I neurons receive nociceptive input (Light et al., '79). 
possibly, this spinal projection to the PB may modulate the autonomic 
responses of the PB to painful stimuli. 
Feeding. Electrical stimulation of the PB, particularly its 
caudal waist area, elicits feeding behavior in the rat (Micco, '74). 
As an anatomical substrate for this response, the PB sends a heavy 
projection to the medullary reticular formation which, in turn, 
projects to motor nuclei involved in oral-facial functions, such as 
mastication and swallowing (Saper and Loewy, '80; Takeuchi et al., '80; 
Travers and Norgren, '83). In addition, the PB projects directly to 
the lateral part of the facial nucleus; this area controls the facial 
muscles surrounding the mouth (Takeuchi et al., 'SO; Saper and Loewy, 
'80). Schwartzbaum ('83) has theorized that the PB integrates 
orolingual (i.e., feeding) responses to taste and other sensory input. 
As evidence, many 'gustatory' neurons in the caudal, medial PB receive 
mechanoreceptive or visceral (i.e., vagal) input (Ogawa et al., '82; 
Hermann and Rogers, '85). In the awake rabbit, most of this 
mechanoreceptive input is related to feedback from orolingual movement 
rather than from the properties of the ingestant (Schwartzbaum, '83). 
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Several lines of evidence suggest that the PB may play a role in 
the regulation of food ingestion. The PB projects heavily to the 
ventromedial hypothalamus (VMH), which has long been implicated in the 
feeding process (for review, Woods et al., '86). A majority of the 
neurons in the superior lateral subnucleus of the PB that project to 
the VMH stain for the neuropeptide, cholescystokinin (CCK) (Fulwiler 
and Saper, '85). In the rat, the VMH contains receptors for CCI< 
(Zarbin et al., '83), and an injection of this neuropeptide into the 
VMH suppresses feeding behaviors (Stern et al., '76; McCaleb and Myers, 
'80). The hyperphagia and obesity produced by VMH lesions can largely 
be abolished by aubdiaphragmatic vagotomy, suggesting that the visceral 
afferent input to the VHH is involved in producing the effects seen 
after VHH ablation (Powley, '77). The PB is the major relay of this 
visceral afferent information to the VMH (Ricardo and Koh, '78; Saper 
and Loewy, '80). Thus, the CCK-containing pathway from the PB to the 
VMH may be important in the regulation of feeding in the hypothalamus. 
Fluid Regulation. Anatomical studies suggest that the PB may play 
a role in fluid and electrolyte balance. The PB is connected with 
several midline structures, such as the area postrema, subfornical 
organ, and median preoptic nucleus (Shapiro and Hiselis, '85; Saper et 
al., '85), which have been implicated in fluid regulation (Simpson, 
'81; Eng and Miselis, '81; Edwards and Ritter, '82). Many cells and 
fibers in the PB stain for the neuropeptides, angiotensin II and 
atriopeptin (Lind et al., '85; Standaert et al., '86b). Both central 
and intravenous administration of angiotensin II result in a strong 
dipsogenic response (Epstein et al., '70; Robinson and Evered, '87), 
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while central administration of atriopeptin attentuates the dipsogenic
actions of angiotensin II (Lappe et al., '86).
Direct, physiological evidence that the PB participates in this 
function can be found in the study by Ohman and Johnson ('86).
Following bilateral ablation of the ventrolateral PB, they noted an
exaggerated drinking response after systemic administration of
angiotensin II and isoproterenol, suggesting an alteration in the 
central thirst mechanisms. 
Micturition. Barrington ('25) first described a 'micturition 
reflex centre' in the dorsolateral pontine tegmentum just ventral to 
the medial edge of the scp. Lesions of this area resulted in an 
inability to empty the urinary bladder. Later experiments, employing 
electical stimulation, lesion and/or HRP techniques, further localized 
this reflex center (i.e., Barringon's nucleus) to the central gray, 
medial to the PB and Mess, and just rostral to locus coeruleus (Lalley 
et al., '72; deGroat, '75; Satoh et al., '78). Recently however, Lumb 
and Morrison ('87) found that either chemical or electrical stimulation 
of the lateral PB also evokes urinary bladder contractions. As the 
lateral PB does not project to the spinal cord, it is unknown by what 
pathways the PB may influence this reflex. 
Endocrine Function. A few studies have implicated the PB in the 
release of hormones from both the anterior and posterior hypophysis. 
Electrical stimulation of dorsal and lateral parts of the PB produces a 
small increase in plasma levels of arginine vasopressin (AVP); this 
effect is markedly increased following ganglionic blockade (Sved, '86). 
The pathway from the PB to the PVH may subserve this response (Fulwiler 
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and saper, '84; Ciriello et al.» '84). And, in an early study, Ward et
al. ('76) noted decreased plasma concentrations of adrenal
corticotropin hormone (ACTH) following electrical stimulation of an
area in the rostral pons of the cat which included the parabrachial
region and locus subcoeruleus. Future studies are needed to more 
precisely locate the source of this response. 
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Table 1. Efferent Connections of ..:ra Parabrachial Nucleus 
(Saper and Loewy, 'BO; Fulwiler and Saper, '84) 
cortex - Infralimbic 
- Insular
Septo-olfactory area
Bed Nucleus of the Stria Terminalis 
Amygdala - Central N. 
- Anterior
- Medial N.
- Basomedial N.
- Posterior Basolateral N.
Substantia Innominata 
Pons - contralateral PB 
- Facial Nucleus
Medulla - N. Solitary Tract 
- Nucleus Ambiguus
- Ventrolateral Medulla
- Reticular Formation
- Hypoglossal N.
Spinal Cord 
Hypothalamus - Preoptic 
- Paraventricular N.
- Lateral
- Ventromedial N.
- Dorsomedial N.
- Arcuate N.
Thalamus - Intralaminar N. 
- Midline N.
- Ventromedial Basal N.
Hidbrain - Substantia Nigra 
- Cen tra 1 Gray
- Edinger-Westphal N.
- Raphe N.
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Table 2. Afferent Connections of the Parabrachial Nucleus 
Bed Nucleus of the Stria Terminalis--------(Swanson and Cowan, '79; 
Holstege et al., '85) 
Central Nucleus of the Amygdala------------(Hopkins and Holstege, '78; 
Krettek and Price, '78; 
Price and Amaral, '81; 
Takeuchi et al., '82; 
Veening et al., '84) 
Lateral Hypothalamus-----------------------(Saper et al., '79; 
Hosoya and Matsushita, '81; 
Berk and Finkelstein, '82; 
Takeuchi and Hopkins, '84) 
Paraventricular N., Hypothalamus-----------(Swanson, '77; 
Takeuchi and Hopkins, '84; 
Luiten et al., '85) 
Preoptic Area of the Hypothalamus----------(Conrad and Pfaff, '76; 
Saper and Levisohn, '83; 
Chiba and Murata, '85) 
Ventromedial/Dorsomedial Hypothalamus------(Takeuchi and Hopkins, '84) 
Insular/Infralimbic Cortex-----------------(Saper, '82; 
Shipley and Sanders, '82; 
van der Kooy et al., '84; 
Yasui et al., '85) 
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Table 2. continued 
Nucleus of the Solitary Tract--------------(Norgren and Leonard, 1 73; 
Norgren, '76, '78; 
Ricardo and Koh, 1 78) 
Area Postrema------------------------------(Shapiro and Miselis, '85) 
ventrolateral Medulla----------------------(Loewy et al., '81) 
Spinal Cord/Spinal Trigeminal Nucleus------(Cechetto et al., '85) 
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Table 3. Peptidergic Pathways of the Parabrachial Nucleus 
source Termination Neuro~e~ tide Reference 
Spinal Cord PB ENK, DYN Standaert et al., '86a 
NTS PB CCK, ENK, SS Mantyh and Hunt, '84 
NT, SP Milner and Pickel, '86a,b 
GAL, NPY, CRF, All Herbert et al.' 1 87 
Ce A PB SP Milner and Pickel, 1 86b 
LH PB SP, NT Milner and Pickel, '86a,b 
PVH PB OXY Swanson, I 77 
PB Thalamus CCK, ENK, NT, Man tyh and Hunt, '84 
SS, SP 
CGRP Shimada et al., 'BS 
PB Raphe Magnus ENK Beitz, '82b 
PB VMH CCK Fulwiler and Sa per, '8S; 
Zaborszky, '84 
CGRP Shimada et a 1., 'SS 
PB LH CGRP Shimada et al., 'BS 
PB MnPO ENK, CRF Lind and Swanson, '84; 
SP Block et a 1. , '84 
PB Ce A NT, SP Block et a 1, 1 83 
CGRP Shimada et al., 'BS 
ENK Zardetto-Smith and 
Gray,' 86 
PB BST CGRP Shimada et a 1. , '8S 
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Figure 1. Drawings of the parabrachial nucleus through four levels 
(rostral to caudal, upper left to bottom right) illustrating the 
approximate locations of the subnuclei. Shaded areas indicate fiber 
tracts. 
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CHAPTER III 
PEPTIDERGIC PATHWAYS FROM THE CENTRAL NUCLEUS 
OF THE AMYGDALA TO THE PARABRACHIAL NUCLEUS 
INTRODUCTION 
The central nucleus of the amygdala (CeA) sends a dense axonal 
projection to the parabrachial nucleus (PB) in the pons (Krettek and 
Price, '78; Price and Amaral, '81; Takeuchi et al., '82). This pathway 
is present in primates (Price and Amaral, '81), cats (Krettek and 
Price, '78) and rats (Krettek and Price, '78; Veening et al., 1 84), and 
is reciprocal (Takeuchi et al., 1 82; Fulwiler and Saper, '84; Veening 
et al., '84). Recent physiological studies have focused on the role of 
the CeA and PB in cardiovascular and respiratory functions. For 
example, electrical stimulation of the central nucleus alters the 
firing rate of neurons in the parabrachial nucleus, some of which are 
also activated by stimulation of the carotid sinus (Cechetto and 
Calaresu, '83). Also, stimulation of either the CeA and/or the PB 
produces respiratory activation and a large pressor response (Mraovitch 
et al., '82; Galeno and Brody, '83; Harper et al.,'84). These findings 
probably reflect the role of the CeA and PB in the integration of 
autonomic responses associated with a variety of adaptive behaviors 
(Kaada, '72; Loewy and McKellar, '80; Smith and DeVito, '84). 
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The CeA contains many different types of peptide immunoreactive 
neurons, each of which exhibits its own characteristic distribution 
within the CeA (Wray and Hoffman, '83, Veening et al., '84; Cassell et 
al., '86). Neurotensin (NT-ir)-, corticotropin releasing factor 
(CRF-ir)-, somatostatin (SS-ir), and enkephalin (ENK-ir)-immunoreactive 
neurons are especially numerous (Roberts et al., '80a; Wray and 
Hoffman, '83; Veening et al., 1 84; Cassell et al., '86) within the CeA. 
Roberts et al. ('80a) has described the CeA as a focus for 
diverging/converging peptide pathways. However, only a few of the 
destinations of these pathways have been reported. For example, 
peptidergic efferents from the CeA to the bed nucleus of the stria 
terminalis (Uhl et al.,'78) and the dorsal vagal complex (Kawai et al., 
'82; Higgins and Schwaber, '83; Veening et al., '84) have been 
identified. As yet, no peptide has been identified in the CeA 
projection to the PB, although a recent attempt was made (Veening et 
al., '84). Data on the organization of peptide pathways between the 
CeA and PB is an important prerequisite for understanding how these 
regions function in the integration of behaviors which have strong 
autonomic components. In this study, we use a modification of the 
combined retrograde tracing and immunocytochemical method (Sawchenko 
and Swanson, '81; Skirboll et al., '84) to test for the presence of 
NT-ir, CRF-ir, SS-ir and ENK-ir in CeA neurons which project to the PB. 
Preliminary findings of this investigation were previously reported 
(Moga and Gray, '84). 
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METHODS 
The subjects of this study were 150-300 gm male Long-Evans rats 
(n•23). Under sodium pentobarbital anesthesia (50 mg/kg), unilateral 
(ns21) and bilateral (n•2) 50 nl injections of 2.0% Fast Blue dye (D.R. 
Iling) in distilled water were made into the parabrachial nuclei with a 
1.0 ul Hamilton syringe fitted with a glass micropipette with an 
outside diameter of 25-50 um. The stereotaxic coordinates (AP.-9.5, 
ML=2.0, DV•-7.1) for the PB were derived from the Paxinos and Watson 
(1982) rat brain atlas. Injections were made over a 15 min. period, 
and the pipette was left in place for a minimum of 10 additional 
minutes. Thirty-six to forty-eight hours prior to sacrifice, each 
animal was re-anesthetized, and 5-7 ul of colchicine (dissolved in 
saline, 10 ug/ul) were injected into each lateral ventricle at 
approximately -0.8 posterior to the bregma level illustrated in Paxinos 
and Watson (1982). Post-Fast Blue injection survival times ranged from 
7 to 10 days. Animals were sacrificed with a lethal dose of sodium 
pentobarbital. They were perfused through the ascending aorta with 
O.OlM phosphate buffered saline (pH 7.6, 38°C) followed by 0.167M 
phosphate buffered 4.0% paraformaldehyde (pH 7.6, 4°c). After 
perfusion, the skull was placed in a stereotaxic frame (Kopf) and the 
brain was sliced into coronal blocks. The blocks of brain tissue were 
post-fixed in 4.0% paraformaldehyde for 30 minutes to 2 hours and then 
cut serially using a vibratome (Lancer). Sections from the injection 
site (40 um) were mounted onto chrom-alum-coated slides. Adjacent 
coronal sections (20 um) of the amygdala and hypothalamus were 
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collected in 3 or 4 vials of cold (4.o0 c) phosphate buffered saline 
(PBS). Each series of adjacent sections was rinsed in PBS containing 
o.1% Triton-X (Mallinckrodt) for 20 minutes followed by a 30 minute 
incubation in normal goat serum (diluted to 10.0% in PBS), and then 
another rinse in PBS (10 minutes). Anti-neurotensin, anti-
met-enkephalin, anti-peptide E, and anti-somatostatin were used at a 
dilution of 1:500; anti-CRF was diluted 1:300. All primary antibodies 
were obtained from Immunonuclear Corporation, except for anti-peptide E 
which was generously supplied by Dr. S.J. Watson. Immunoabsorption of 
the above antisera with homologous antigen served as controls for 
specificity. Each set of sections was gently agitated in one of the 
above primary antiserum at room temperature for 60 minutes, and then in 
a cold room (4°C) for 14-24 hours. Next, the sections were rinsed in 
PBS and incubated in rhodamine-conjugated goat antirabbit IgG (Cooper 
Biomedical, diluted 1:10 in PBS-Triton-X) at 45°c for 10 min. and then 
at room temperature for 60 minutes. Sections were transferred to cold 
PBS and mounted onto chrom-alum-coated slides, and cover-slipped using 
DePeX (BDH Chemicals) mounting media. The material was examined with 
an Olympus microscope equiped with a lOOW mercury light source. Fast 
Blue was visualized with an excitation wavelength centered at 330-360 
nm (Olympus ultraviolet filter system). Rhodamine immunofluorescence 
was viewed with the Olympus green (546 nm) filter system. Cells that 
contained both Fast Blue and rhodamine immunofluorescence were detected 
by switching between filter systems. Sections were photographed with 
Polaroid coaterless land pack film 667, ASA 3000/36 DIN. In three 
cases with comparable and extensive CeA retrograde labeling, the 
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retrograoely labeled, neuropeptide- immunoreactive and double-labeled
neurons in the CeA were counted (from every one out of four sections
through the CeA) using a 40x UV fluorite objective.
RESULTS 
Distribution of Retrogradely Labeled Neurons 
The distribution of retrogradely labeled cells varied depending on 
the site of the injection in the PB. A maximal number of retrogradely 
labeled neurons within the CeA was obtained in animals with injections 
located at mid-rostrocaudal levels in the PB. With injections centered 
in the ventrolateral PB (Fig. lC, E-G), heavy labeling occurred 
throughout the rostrocaudal extent of the CeA in all subdivisions (e.g. 
Fig 5A). With injections centered in the lateral PB (e.g., Fig. lB), 
labeled cells were found throughout the rostrocaudal extent of the 
ipsilateral CeA but were located predominantly in its caudal half 
within the lateral and lateral capsular subdivisions. Light labeling, 
located primarily within the medial CeA, was seen with injections 
centered within the medial PB (e.g Fig. lD) and the dorsomedial PB 
(e.g. Fig. lH). Labeling was not observed in the CeA in animals with 
injections located in the cuneiform nucleus or adjacent regions of the 
cerebellum. 
After injections into the PB, retrogradely labeled neurons were 
also observed in the anterior amygdaloid area, ventral pallidum, 
intercalated cell group of the amygdala, substantia innominata, organum 
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vasculosum of the lamina terminalis, median preoptic nucleus, lateral 
and medial preoptic areas, infralimbic cortex, insular cortex, lateral 
prefrontal cortex, bed nucleus of the stria terminalis, retrochiasmatic 
area, zona incerta, lateral hypothalamus, paraventricular hypothalamus, 
dorsomedial hypothalamus, and arcuate nucleus. Retrograde labeling in 
all of the above areas was predominantly ipsilateral to the injection 
site; however, a few contralaterally labeled cells were always present. 
Distribution of Immunoreactive Neurons 
The distribution of CRF-ir, NT-ir, SS-ir and ENK-ir cells within 
the CeA was the same as that described in previous immunocytochemical 
studies of the CeA (Wray and Hoffman, '83; Veening et al, '84; Cassell 
et al, '86); therefore, the present findings are only briefly 
summarized. CRF-ir and NT-ir immunoreactive neurons were mainly 
confined to the lateral subdivision of the CeA with only an occasional 
CRF-ir or NT-ir neuron seen in the medial and lateral capsular 
subdivisions. Most of the SS-ir neurons were observed within the 
lateral subdivision of the CeA, although SS-ir neurons were also 
commonly seen in the medial CeA. The immunoreactivity observed using 
antibodies to met-enkephalin and peptide E appeared indistinguishable 
and hereafter will be referred to as enkephalin-immunoreactivity 
(ENK-ir). ENK-ir neurons were distributed within the lateral and 
lateral capsular subdivisions of the CeA. 
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DoubI2-Labeled Neurons 
Neurons labeled for both neuropeptide and retrograde tracer were 
consistently found in the lateral subdivision of the CeA. Few 
double-labeled neurons were found in the medial and lateral capsular 
subdivisions. In three cases, the injections (Fig. 1 - E, F, G) were 
centered in the ventrolateral PB, and comparable retrograde labeling 
was found throughout the CeA. Immunoreactive and double-labeled 
neurons in the CeA after these injections were counted (Table 1) to 
assess the relative contribution of each neuropeptide to the CeA-PB 
pathway. These cell counts include labeled cells from every CeA 
subdivision. Figures 2-5 are photomicrographs of retrogradely labeled, 
immunoreactive and double-labeled cells in the CeA at its 
mid-rostrocaudal extent (approximately the bregma -2.8 mm level 
illustrated in the Paxinos and Watson ('82) atlas). Figure 6 shows the 
characteristic distributions of double-labeled cells within the CeA for 
each neuropeptide examined. 
Neurotensin (NT-ir). Cells double-labeled for NT-ir and fast blue 
were numerous and were concentrated in the caudal half of the CeA 
within its lateral subdivision. A few double-labeled cells were 
observed in the lateral capsular subdivison. Many (40-53%) NT-ir 
neurons in the CeA were retrogradely labeled. Figure 2 shows an 
example of three retrogradely-labeled NT-ir cells and their location in 
the CeA. NT-ir double-labeled cells were also seen in the intercalated 
cell group of the amygdala, lateral division of the bed nucleus of the 
stria terminalis (BST), perifornical area of the lateral hypothalamus 
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and parvocellular subdivision of the paraventricular nucleus of the 
hypothalamus. 
Corticotropin Releasing Factor (CRF-ir). Many CRF-ir cells were 
labeled with fast blue, and they were found predominantly at caudal 
levels in the lateral subdivision of the CeA, although a few 
double-labeled neurons were seen in the medial subdivison. Of the four 
types of peptidergic neurons studied in the CeA, CRF-ir neurons 
exhibited the highest percentage (54-66%) of cells retrogradely labeled 
with Fast Blue. An example of CRF-ir neurons labeled with Fast Blue is 
presented in Figure 3. Additional double-labeled CRF-ir neurons were 
located in the intercalated cell group of the amygdala, the lateral 
division of the BST, lateral hypothalamus-perifornical area and the 
parvocellular paraventricular nucleus of the hypothalamus. 
Somatostatin (SS-ir). Cells double-labeled for Fast Blue and 
SS-ir were observed in the CeA following injections of tracer into the 
PB. The percentage of SS-ir neurons labeled with Fast Blue was lower 
than that for CRF-ir and NT-ir, and ranged from 31-50%. Double-labeled 
SS-ir neurons were for the most part limited to the lateral subdivision 
although a few cells were located in the medial subdivison. Their 
distribution extended more rostrally than doubled-labeled NT-ir or 
CRF-ir neurons. Figure 3 shows an example of two somatostatin-
immunoreactive cells in the lateral CeA which were also retrogradely 
labeled with Fast Blue. Cells labeled for both SS-ir and Fast Blue 
were also seen in the lateral division of the BST and the lateral 
hypothalamus. 
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Enkephalin (ENK-ir). Cells double-labeled for ENK-ir and Fast 
Blue were never observed in the CeA after injections of the tracer into 
the pB. However, ENK-ir cells were often observed adjacent to Fast 
Blue labeled cells (Figure 5). A few double-labeled ENK-ir cells were 
observed in the medial preoptic area and the parvocellular paraven-
tricular nucleus of the hypothalamus. 
DISCUSSION 
In the present study, the combined retrograde tracing-
immunofluorescence method was used to identify the presence of CRF-ir, 
NT-ir and SS-ir in CeA neuronal efferents to the PB. The percentage of 
CRF-ir, NT-ir and SS-ir double-labeled cells per subject showed little 
variation, i.e., 54-667., 40-53% and 31-50%, respectively (see Table 1). 
However, the total number of CRF-ir, NT-ir and SS-ir immunoreactive 
neurons per subject tended to vary considerably, from 85-183, 60-194 
and 100-129, respectively. These data illustrate two important points 
concerning interpretation of the results of this double-labeling 
technique. First, this technique provides a conservative estimate of 
the number of immunoreactive neurons contributing to a particular 
pathway. Second, in judging the relative contribution of a peptidergic 
population to a neural pathway, the percentage of neurons participating 
rather than the absolute number should be considered as a more reliable 
index. This confirms the observations of two recent studies reviewing 
the limitations and applicability of the combined retrograde tracing-
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illllllunocytochemical method (Sawchenko and Swanson, '81; Sk!rboll et al., 
'84). 
CeA Projection to the PB 
Hany investigators have noted that the majority of peptide-
containing neurons in the CeA are located within its lateral 
subdivision (e.g., Wray and Hoffman, 1 83; Veening et al., '84) and 
yet, most of its major efferent projections have been reported to arise 
from cells located in the medial subdivision (Hopkins and Holstege, 
'78; Schwaber et al., '82; Veening et al., '84; Cassell et al., '86). 
Our results show that a large part of the CeA-PB pathway originates 
from the lateral CeA. Results from several tracing studies (Hopkins 
and Holstege, '78; Krettek and Price, '78; Price and Amaral, '81) have 
indicated that the CeA projection to the PB terminates throughout both 
medial and lateral PB without any apparent topography. Recently, Saper 
(unpublished data, discussed in Fulwiler and Saper, '84) reported that 
the CeA projects to distinct areas within the PB, most probably to the 
central, ventral and external lateral subnuclei, the 'waist area' and 
the medial PB. In the present study, optimal retrograde labeling in 
the lateral CeA was obtained with injections centered in the central, 
ventral and external lateral subnuclei described by Fulwiler and Saper, 
'84. Injections centered within the medial or dorsomedial PB resulted 
in labeling confined mainly to the medial CeA. The lateral and medial 
CeA may project to different, yet overlapping, areas within the PB. 
Possibly, veening et al. ('84) were unable to find a CeA peptidergic 
r 
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projection to the PB because their tracer injections missed the
subzones of the PB that receive projections from the lateral CeA. This
explanation seems likely since they reported that their retrograde 
labeling was located predominantly in the medial CeA where very few 
peptidergic neurons are located. Further studies are needed to clarify 
possible hodological differences between the medial and lateral CeA. 
CeA and PB Peptidergic Afferents and Efferents 
Three CeA peptidergic projection zones have been identified. The 
PB and the BST, the major target zones, receive input from a signifi­
cant percentage of corticotropin releasing factor-, neurotensin- and 
somatostatin-immunoreactive neurons in the CeA (Uhl et al., '78; Gray, 
unpublished observations). A small number of CRF-ir, NT-ir and SS-ir 
neurons contribute to the CeA pathway to the DVC (Kawai et al., 1 82; 
Higgins and Schwaber, '83; Veening et al., '84). Enkephalin• 
immunoreactive neurons within the CeA send efferents to the BST (Uhl et 
al., '78), but probably do not innervate the PB or the DVC (Veening et 
al., '84). All of these peptidergic pathways arise primarily from the 
lateral CeA, except for the SS-ir projection to the DVC which 
originates from both medial and lateral CeA (Higgins and Schwaber, '83; 
Veening et al., ' 84). 
Only a few C7a peptidergic afferents have been described. 
Cholecystokinin-immunoreactive (CCK-ir) terminals in the CeA arise from 
the ventral tegmental-substantia nigra region (Hokfelt et al., 1 80). 
Vasoactive intestinal polypeptide-immunoreactive fibers travel to the 
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CeA via the medial forebrain bundle and probably originate from cells
located in the central grey matter (Marley et al., '81). NT-ir fibers
in the CeA arise from the caudal brainstem, possibly from either the PB
and/or the DVC (Kawakami et al., 1 84). 
Thus, significant gaps still remain in our knowledge of the 
peptidergic pathways of the CeA. In particular, the peptide content of 
CeA pathways to the hypothalamus, central grey and A5 catecholamine 
cell group is unknown. 
A number of peptidergic efferents and afferents of the PB have now 
been identified. As already noted, the CeA is a major source of 
CRF-ir, SS-ir and NT-ir terminals to the PB. In smaller numbers, the 
bed nucleus of the stria terminalis, lateral hypothalamus and 
paraventricular nucleus of the hypothalamus also contribute CRF-ir, 
NT-ir and SS-ir fibers to the PB. Notably, enkephalin-ir neurons in 
the CeA do not project to the PB, however, ENK-ir neurons in the medial 
NTS do project to the PB (Mantyh and Hunt, '84). Also from the caudal 
brainstem, the PB receives neurotensin-, somatostatin-, substance P 
(SP-ir)-, cholecystokinin-, and avian pancreatic polypeptide (probably 
neuropeptide Y, Lundberg et al., '84)-immunoreactive fibers from the 
medial NTS (Milner et al, '84; Mantyh and Hunt, '84). Regarding the 
efferents of the parabrachial nucleus, Mantyh and Hunt ('84) have found 
CCK-ir, ENK-ir, NT-ir, SS-ir and SP-ir in the PB projection to the 
ventral part of the thalamus. Other efferent peptidergic populations 
reported in the PB include a CCK-ir projection to the ventromedial 
hypothalamus (Zaborszky, '84; Fulwiler and Saper, '85), and CRF-ir and 
ENK-ir projections to the median preoptic area (Lind and Swanson, '84). 
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From this accumulating mass of peptidergic data on the PB, there 
emerge certain areas of terminal overlap. Most conspicuous is the 
convergence of both forebrain and caudal brainstem NT-ir fibers to the 
ventrolateral PB. In their combined use of immunocytochemistry and 
autoradiography, Milner et al. ('84) found an overlapping distribution 
of NT-ir fibers and anterogradely labeled terminals from the caudal and 
•edial HTS in the ventrolateral PB. They postulated that NT-ir may be 
contained within the efferents of the medial NTS to the PB, an 
observation later confirmed by Hantyh and Hunt ('84). In this study, 
we observed many retrogradely labeled NT-ir cells in the CeA following 
injections into this ventrolateral quadrant. Thus, the ventrolateral 
PB may be an important region for the interaction of NT-ir neurons 
located in both CeA and medial NTS. 
Functional Considerations 
Physiological and anatomical studies indicate that the central 
nucleus mediates the autonomic components of behavioral responses to 
stress-inducing environmental stimuli (e.g., attack and defense 
behaviors, responses to aversive stimuli). Among the amygdalar nuclei, 
only the CeA has strong reciprocal connections with brainstem autonomic 
regions (for review, see Price and Amaral, '81). Reflecting these 
autonomic connections, CeA stimulation in the rat and cat elicits 
cardiovascular, respiratory and gastric responses which are typically 
seen during stress-related behaviors (e.g. Henke, '82; Galeno and 
Brody, '83; Frysinger et al., '84). The cardiovascular (i.e. pressor) 
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response obtained from the awake rat consists of tachycardia, elevated 
mean arterial pressure, renal and mesenteric vasoconstriction, and 
vasodilation in skeletal muscle (Galeno and Brody, '83). This response 
is strikingly similar to the pressor response observed following 
stimulation of the parabrachial nucleus in the cat (Mraovitch, '82). 
Correspondingly, respiratory responses elicited from CeA stimulation 
are nearly identical to those obtained from the PB (Harper et al., 
'84). Thus, the CeA cardiovascular and respiratory responses may be 
mediated through direct projections to the PB. In contrast, gastric 
changes observed following stimulation of the CeA are more likely 
mediated via direct projections to the dorsal vagal complex (Henke, 
'82). 
The CeA has also been implicated in responses to noxious input. 
For example, lesions in the amygdala have been shown to reduce an 
animal's reaction to painful stimulation (Schreiner and Kling, '53). 
More recently, direct injections of neurotensin into the CeA of the rat 
produced a significant increase in the nociceptive threshold of the rat 
(Kalivas et al., '82). Substantial evidence now exists linking pain 
and cardiovascular pathways (for review, see Randich and Maixner, '84). 
Since the central nucleus is involved in both cardiovascular responses 
and affective reactions to noxious inputs, the linkage of pain and 
cardiovascular function may occur partially in the CeA. This possible 
linkage of nociception, pressor response and respiratory activation 
within the CeA may provide an anatomical basis for the proposal of 
Randich and Maixner ('84) that elevations in blood pressure, with a 
subsequent inhibition of pain and/or associated behavioral changes, may 
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reduce the stress experienced by an animal during aversive environ-
mental stimulation. 
Other recent studies have emphasized the importance of the CeA in 
the development of pathological responses to stress. For example, 
chronic stimulation of the CeA produces gastric ulcers; and bilateral 
ablation of the CeA reduces the incidence and severity of stress-
induced gastric ulcers in the rat (Henke, '82). Bilateral ablation of 
the CeA or its output pathways also attenuates the translation of noise 
stress into increased sympathetic nerve activity in both normotensive 
and spontaneously hypertensive (SHR) rats (Galeno et al., '84). Galeno 
et al. ('84) speculate that the enhanced pressor response of the SHR 
rat to noise stress may be the result of an abnormal amplification of 
sensory information through the amygdala. Such a hypothesis is 
consistent with the multiplicity of sensory inputs to the CeA (Turner, 
'81; Ottersen, '81). 
Neuropeptides found in the CeA and its output pathway to the PB are 
also involved in stress responses. For example, intracisternal 
administration of neurotensin and somatostatin reduces the incidence of 
stress-induced gastric ulcers in rats (Hernandez et al., '83). Intra-
cerebroventricular application of corticotropin releasing factor 
stimulates sympathetic outflow (i.e., tachycardia, increased blood 
pressure, vasoconstriction); and these effects probably occur through 
actions in the brain rather than through the neuroendocrine system 
(Brown et al., 1 82; Sutton et al., '82). We speculate that CRF, NT and 
SS may be important putative neurotransmitters in the CeA-PB pathway, 
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and that this peptidergic pathway may be an important mediator of 
stress-related responses. 
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Figure l. Drawings of the relative positions of representative Fast 
Blue injections in the parabrachial nucleus. Black shading indicates 
the center of each injection site where necrosis occurred. Hatched 
areas represent the apparent spread of the fluorescent dye. 
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Figure 2. Fluorescent photomicrographs of a coronal section through 
the caudal CeA illustrating the distribution of (A) cells projecting to 
the PB and (B) cells immunoreactive to neurotensin. Figures C (Fast 
Blue-labeled cells) and D (NT-ir cells) are high power photomicrograph& 
of three double-labeled cells (indicated by white arrows) found within 
the lateral subdivision of the CeA in A and B. (L, lateral 
subdivision; LC, lateral capsular subdivision; M, medial subdivision; 
st, stria terminalis). Bar• 100 um. 
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Figure 3. Fluorescent photomicrographs of a coronal section through 
the caudal CeA illustrating the distribution of (A) cells projecting to 
the PB and (B) cells immunoreactive to corticotropin releasing factor. 
Figures C (Fast Blue-labeled cells) and D (CRF-ir cells) are high power 
photomicrographs of 2 double-labeled cells (indicated by white arrows) 
found within the lateral subdivision of the CeA in A and B. (L, 
lateral subdivision; LC, lateral capsular subdivision; M, medial 
subdivision; st, stria terminalis). Bar = 100 um. 
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Figure 4. _Fluorescent photomicrographs of a coronal section through 
the caudal CeA illustrating the distribution of (A) cells projecting to 
the PB and (B) cells immunoreactive to somatostatin. Figures C (Fast 
Blue-labeled cells) and D (SS-ir cells) are high power photomicrographs 
of 2 double-labeled cells (indicated by white arrows) found within the 
lateral subdivision of the CeA in A and B. (L, lateral subdivision; 
LC, lateral capsular subdivision; M, medial subdivision; st, stria 
terminalis). Bar a 100 um. 
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Figure 5. Fluorescent photomicrographs of a coronal section through 
the caudal CeA illustrating the distribution of (A) cells projecting to 
the PB and (B) cells immunoreactive to enkephalin. Figures C (Fast 
Blue-labeled cells) and D (ENK-ir cells) are high power photomicro-
graphs of cells found in A and B. Note the absence of double-labeled 
cells. (L, lateral subdivision; LC, lateral capsular subdivision; M, 
medial subdivision). Bar• 100 um. 
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Figure 6. Summary diagram illustrating the characteristic 
distributions of Fast Blue (0), peptide-immunoreactive (e), and 
double-labeled (~) cells within the CeA. Part A is a line drawing of 
the CeA, its subdivisions and neighboring nuclei; it is derived from 
the Paxinos and Watson (1982) atlas. The medial subdivision of the CeA 
depicted here includes both ventral and medial subdivisions described 
by Cassell et al. (1985). Parts B-E show the distributions, 
respectively, of neurotensin-, corticotropin releasing factor-, 
somatostatin- and enkephalin-immunoreactive cells within the CeA and 
their relation to both double-labeled and Fast Blue labeled cells. 
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Table 1. Number and percent of bununoreac ti ve cells 
in the CeA that contain Fast Blue 
Nwnber of Number of Number of Percent of 
sections immunoreac ti ve double-labeled double-labeled 
antigen subject sampled cells cells cells 
------- -------
--------- -------------- -------------- -------------..... CRF E 14 85 56 66 
F 14 133 73 55 
G 14 183 98 54 
NT E 13 60 31 52 
F 12 15 30 40 
G 10 194 102 53 
SS E 16 129 55 43 
F 16 113 56 50 
G 17 100 31 31 
ENK E 13 81 0 
F 11 67 0 
G 10 48 0 
1. The injection sites for subjects E, F and G are presented 
in Figure 1. 
2. The total number of sections that contained immunoreactive 
cells in each subject. 
3. The total number of cells that contained both Fast Blue and 
immunof luorescence. 
CHAPTER IV 
PEPTIDERGIC PATHWAYS FROM THE BED NUCLEUS 
OF THE STRIA TERMINALIS TO THE PARABRACHIAL NUCLEUS 
INTRODUCTION 
The bed nucleus of the stria terminalis (BST) is a rostral 
forebrain structure closely related to the amygdala, its major source 
of afferent input (Weller and Smith, '82; DeOlmos et al., 1 85;). The 
BST has traditionally been divided into medial and lateral subdivisions 
(Krettek and Price, '78; DeOlmos et al., '85). The medial subdivision 
is extensively connected with nuclei, such as the medial preoptic 
nucleus, ventromedial hypothalamus and medial nucleus of the amygdala, 
that are involved in neuroendocrine regulation and reproductive 
behaviors (Swanson, '76; Saper et al., '76; Krettek and Price, '78). 
In contrast, the lateral subdivision (BSTL) is distinguished by its 
reciprocal connections with nuclei involved in central autonomic 
regulation (Loewy and McKellar, 'BO). In particular, the BSTL sends a 
dense projection to the parabrachial nucleus in the pons (Holstege et 
al., '85). Physiological studies have implicated the PB in a variety 
of autonomic functions, including fluid regulation (Ohman and Johnson, 
'86), and cardiovascular (Mraovitch et al., '82) and respiratory 
(Cohen, '71) responses. In contrast, few studies have examined the 
role of the BSTL in autonomic function (Swanson and Sharpe, '73; Hilton 
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and Spyer, '71). However, based on the size of the BSTL-PB pathway, 
the BSTL may be an important modulator of PB function. 
The BST contains many different types of neuropeptide-
immunoreactive neurons, each of which exhibits its own characteristic 
distribution within the BST (Woodhams et al., '83). Neurotensin 
(NT-ir)-, corticotropin releasing factor (CRF-ir)-, somatostatin 
(SS-ir)-, and enkephalin (ENK-ir)-immunoreactive neurons are especially 
numerous within the lateral subdivision of the BST (Woodhams et al., 
1 83; Swanson et al., '83). Possibly, some of these peptidergic neurons 
may contribute to the BSTL-PB pathway. 
Recently, neurons in the central nucleus of the amygdala (CeA) 
that project to the PB were found to stain for CRF-ir, NT-ir and SS-ir 
but not for ENK-ir (Moga and Gray, '85b). Other studies have 
demonstrated that Golgi-stained neurons in the BSTL and CeA are similar 
in appearance (McDonald, '83) and that both nuclei project to similar 
areas in the brainstem (Schwaber et al., '82). A study of the 
peptidergic projection from the BSTL to the PB would provide further 
data for anatomical comparisons between BSTL and CeA. In this study, 
using the combined retrograde tracing- immunohistochemical method, I 
examine whether CRF-, NT-, SS- or ENI<- immunoreactivity is present in 
BSTL neurons that project to the PB. 
To accurately map the retrogradely labeled, immunoreactive and 
double-labeled neurons observed within the BSTL in this experiment, I 
first examined the cytoarchitecture of the BST in Nisal-atained 
sections, and in so doing, observed a number of distinct cell groups 
within the BST. Recently, investigators have noted additional 
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subdivisions within the BST (e.g., DeOlmos et al., '85; McDonald, '83) 
but there has been no complete description of the BST subnuclei. Thus, 
8 description of the subnuclear organization of the BST, based on my 
observations of Nissl-stained sections, is also included in this study. 
preliminary findings of this study were previously reported (Hoga and 
Gray, '85a; Moga et al., '87). 
METHODS 
TWenty-one male Long-Evans rats (250-350g) were used in this 
study. Each animal was anesthetized with 7% chloral hydrate. 
Injections (50-100 nl) of 2% Fast Blue (D. R. Iling) were made into the 
parabrachial nucleus with a 1.0 ul Hamilton syringe fitted with a glass 
micropipette. Injections were made over a 15-minute period, and the 
pipette was left in place for an additional 10 minutes. After 11-13 
days survival, the animals were treated with 150-200 ug colchicine 
(Sigma) in 10 ul saline injected into the lateral ventricle. 
Thirty-six to 48 hours later, the animals were reanesthetized with 
chloral hydrate and then perfused through the heart with O.OlM 
phosphate-buffered saline (pH 7.6, 37°c) followed by O.lH phosphate-
0 buffered 4% paraformaldehyde (pH 7.6, 4 C). After perfusion, the skull 
was placed in a stereotaxic frame (Kopf), and the brain was sliced into 
coronal blocks. The blocks of brain tissue were post-fixed in 4% 
paraformaldehyde for 30 minutes to 2 hours and then cut aerially on a 
vibratome (Lancer). Sections from the injection site (40 um) were 
mounted onto chrom-alum-coated slides. Adjacent coronal sections 
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(20 um) of the forebrain were collected in four vials of cold 
phosphate- buffered saline (PBS). Each series of adjacent sections was 
rinsed in PBS for 20 minutes and then placed in a primary antiserum 
with gentle agitation for 14-24 hours in a cold room (4°c). After the 
overnight incubation in primary antibody, the sections were then rinsed 
in PBS for 20 minutes, incubated in biotinylated goat anti-rabbit lgG 
(Bethesda Research Laboratory) for 30 minutes at room temperature, 
rinsed again in PBS for 15 minutes, and incubated in atreptavidin-Texas 
Red (Bethesda Research Laboratory) for 30 minutes. All sections were 
then transferred to cold PBS, mounted onto chrom-alum-coated slides, 
and coverslipped with DePeX (BDH Chemicals). 
The following primary antisera were used in this study: 
anti-corticotropin releasing factor (lot #465), provided by Dr. T.L. 
O'Donohue (Olschowka et al., '82); anti-neurotensin (lot #8351022) and 
anti-somatostatin (lot #8535027), obtained from the Immunonuclear 
Corporation (Emson et al., '82; Kohler and Chan-Palay, '82), and 
anti-met-enkephalin, provided by Dr. R. Elde (Haber and Elde, '82). 
The antisera were diluted 1:500 (SS, ENK, NT) and 1:2000 (CRF) in a 
solution containing PBS, 0.1% Triton-X-100 (Mallinckrodt) and 1% normal 
goat serum. As a control for antisera specificity, 1 ml of each 
diluted antisera was preincubated with 25-50ug of its respective 
synthetic neuropeptide for one hour, and the sections processed as 
usual to determine whether any residual staining remained. Although 
immunohistochemical staining was eliminated in these controls, it is 
possible that these antisera may recognize unidentified neuropeptides 
containing similar amino acid sequences. Thus, the neuropeptide 
60 
immunoreactivity detected in this study is more accurately described as
neuropeptide-like immunoreactivity (-ir), reflecting our uncertainty as 
to the precise targets of the antisera.
All material was examined with an Olympus microscope equipped with 
a lOOW mercury light source. Fast Blue was visualized with an 
excitation wavelength centered at 330-360 nm (Olympus ultraviolet 
filter system). Texas Red immunofluorescence was viewed with the 
Olympus green (546 nm) filter system. Cells that contained both
retrograde fluorescence and immunofluorescence were detected by 
switching between filter systems. Sections were photographed with 
Polaroid coaterless Land pack film 667, ASA 3000. The distributions of 
labeled cells were plotted with a Leitz Ortholux microscope (filter 
systems A and NZ) equipped with digital stage position readout heads 
{Minnesota Datametrics, MD-1). The x- and y-coordinates of the labeled 
neurons were recorded by a Rockwell AIM 65 microcomputer and then 
plotted onto an x-y plotter. After plotting, the slides were soaked in 
xylene to remove the coverslips, and then counterstained with thionin 
to determine the subnuclear location of the labeled cells. 
For the cytoarchitectural study, 15 micron sections were cut from 
paraffin embedded rat brains in both the coronal and sagittal planes, 
and then stained with thionin. These sections were examined and 
photographed to determine the subnuclear boundaries within the BST. 
Neurons in the BST were characterized according to their size and 
shape, the distinctiveness of their nucleolus, and the pattern and 
intensity of their cytoplasmic staining. Clusters of neurons with 
identical characteristics were defined as a subnucleus. 
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RESULTS 
BST Subnuclei 
My observations of the BST subnuclei agree, in general, with the 
brief description of DeOlmos et al., '85, and so, I have retained their 
terminology while preparing the following description. Based on its 
cytoarchitecture and connections, the BST may be divided into medial, 
lateral and ventral subdivisions (Moga et al., '87). The medial BST 
begins at the dorsomedial border of the nucleus accumbens and extends 
to the rostral border of the thalamus; thus, it spans the entire 
rostro-caudal length of the BST. This subdivision may be divided into 
anterior medial, posterior medial, posterior intermediate, 
subventricular, intermediate and ventral medial subnuclei. The 
anterior medial (AM) subnucleus forms the most rostral extent of the 
medial BST (Fig. lA). AM consists of a heterogeneous cell population 
which includes small, ovoid, dark staining cells with little cytoplasm 
and large, medium staining cells with coarse granular cytoplasm. 
Caudally, cells in AH merge imperceptibly with those in the posterior 
medial subnucleus; however, these two nuclei are separated by the body 
of the post-commissural stria terminalis. The intermediate (IM) 
subnucleus forms a wedge of cells rostrally between AM and the anterior 
lateral (AL) subnucleus, and is just dorsal to the anterior commissure 
(Fig. lB). In succeeding sections, IM can be distinguished by its 
medium-sized, pale-staining cells which are located between AL and the 
receding anterior commissure (Fig. lC). Ventral medial (VM) BST 
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consists of loosely-packed, medium-staining, fusiform-shaped cells 
located beneath the anterior commissure and oriented parallel to it 
(Fig. lB). VM extends caudally, ventral and lateral to the receding 
anterior commissure, to form a closely packed, ovoid group surrounded 
by the IM, posterior lateral and ventral lateral BST subnuclei, and the 
parastrial nucleus (Fig. lD). The posterior medial (PM) subnucleus 
consists of medium staining, tightly packed neurons partially 
encapsulated by a cell-poor area (Fig. lE-G). Rostrally, PM is a 
distinctive round cluster located above the receding anterior 
commlssure (Fig. lE); caudally, as the fibers from the fornix and stria 
medullarls descend, PM shifts to form a tight band of cells oriented 
diagonally (Fig. lF,G). Posterior intermediate (PI) BST lies between 
the band-shaped PM, medially, and posterior lateral and preoptic BST, 
laterally (Fig. lG). PI consists of medium staining neurons which are 
similar to, but more loosely packed, than those in PM. Subventrlcular 
BST (SV), a small oval-shaped subnucleus located beneath the surface of 
the lateral ventricle, consists of small, ovoid, closely packed neurons 
with indistinct nucleoli (Fig. lD). 
The lateral BST can be divided into dorsal, ventral, posterior, 
supracapsular and juxtacapsular subnuclei. The dorsal lateral (DL) 
subnucleus ls an oval-shaped, homogeneous cluster of round, lightly-
stainlng neurons with a prominent nucleolus and little cytoplasm (Fig. 
lB,C), This distinctive cell cluster ls found throughout the rostral 
half of the BST, dorsal to the anterior commissure and adjacent to the 
caudate-putamen and internal capsule. With the crossing of the 
anterior commissure, DL moves dorsally to become continuous with cells 
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in the supracapsular (SC) subnucleus. SC consists of cells 
encapsulated within the fibers of the stria terminalis; these cells 
resemble a number of BST cell types, predominantly those in DL, and are 
found throughout the course of the stria (Fig. lE). DL is surrounded 
medially and ventrally by the anterior lateral (AL) subnucleus (Fig. 
lB,C). AL neurons are medium-staining and teardrop-shaped with an 
indistinct nuclear border and little cytoplasm; they are oriented 
parallel to the strial fibers which surround DL. The posterior lateral 
(PL) subnucleus first appears at mid-BST levels (i.e., the crossing of 
the anterior commissure) as scattered cells beneath AL and DL (Fig. 
lC). More caudally, PL is found adjacent to the juxtacapsular 
subnucleus and the internal capsule in a position formerly occupied by 
AL and DL (Fig. lD-F). Cells within PL are medium-sized, multipolar 
and medium-staining with one to two nucleoli. The juxtacapsular (JXC) 
subnucleus is a loosely packed, lens-shaped cluster of Slllall, round, 
lightly-staining cells lying between the internal capsule, laterally, 
and DL, AL and PL, medially (Fig. lD). 
Ventral BST includes the ventral lateral and preoptic BST 
subnuclei, and the parastrial nucleus. When viewed in the sagittal 
plane, ventral lateral (VL) BST appears as two clusters of cells. 
Rostral VL is a heterogeneous cell cluster distinguished by its 
medium-dark staining, closely packed, fusiform cells oriented in a 
horizontal (i.e., medial to lateral) direction (Fig. lB). caudal VL 
contains large, darkly staining, closely packed, multipolar cells with 
prominent nucleoli; these cells resemble the preoptic neurons which are 
scattered beneath VL (Fig. lD). The parastrial (PS) nucleus is a 
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lens-shaped nucleus located bene.h th the anterior commissure between the 
BST and the cell-poor •trial part of the preoptic area (Raisman and 
Field, '73; Simerly et al., '84). PS contains small, darkly staining, 
ovoid to fusiform cells which are tightly packed and are oriented 
diagonally from the anterior commissure to VL (Fig. lB-E). The PS has 
been considered separate from the BST due to its lack of amygdala input 
(Raisman and Field, '73; Simerly et al., '84). However, cytoarchi-
tecturally, the PS appears continuous with VL at rostral BST levels. 
Both VL and PS contain similar neuropeptide-immunoreactive cells and 
fibers. And, the ventral BST cell groups (i.e., VL, PS and the 
preoptic BST) are extensively connected with the hypothalamus (Moga et 
al., '87). These findings suggest that PS is related to the other 
ventral BST subnuclei and have led us to include the PS in this 
description. 
The preoptic (PO) subnucleus consists of large, 11.ultipolar, 
dark-staining neurons and is located caudally, ventral to PI and PM. 
PO may be divided into medial and lateral portions. Lateral PO is 
adjacent to the internal capsule and dorsal to the medial forebrain 
bundle; its neurons are oriented perpendicular to the descending atrial 
fibers (Fig. lG; McDonald, '83). Medial PO forms an ovoid cluster, and 
has been previously described as the preoptic continuation of the BST 
(Fig. lF; Swanson, '76). 
Distribution of Retrogradely Labeled Neurons 
After Fast Blue injections into the parabrachial nucleus, 
retrogradely labeled neurons were found throughout the forebrain in 
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nuclei previously shown to project to the PB (e.g., central nucleus of 
the amygdala, lateral hypothalamus, paraventricular hypothalamus). 
These afferent cell populations are described in detail in another 
study (Moga et al., in preparation). Within the BST, retrogradely 
labeled neurons were numerous in the lateral subdivision throughout its 
rostrocaudal extent. However, the distribution of the labeled neurons 
within BSTL varied with the site of injection in the PB. After 
injections centered in the external lateral PB subnucleus (Fig. 2A; for 
PB subnuclei, see Fulwiler and Saper, '84), many intensely labeled 
neurons were found in the dorsal lateral, anterior lateral and 
supracapsular BST subnuclei with only a small number of lightly labeled 
neurons in the ventral lateral and posterior lateral subnuclei. In 
contrast, after injections centered in either the ventral lateral or 
medial PB subnuclei (Fig. 2B), a large number of intensely labeled 
neurons was found in the posterior lateral subnucleus with few labeled 
neurons in DL, AL PO, VL, and VM. When injections included the 
rostral, lateral portion of the medial PB subnucleus (Fig. 2C), neurons 
in the ventral lateral BST subnucleus showed intense labeling. 
Injections into the caudal waist area of PB (Fig. 2D) showed a mixed 
pattern of labeling; many labeled cells were found throughout the 
lateral BST subnuclei. 
After a lateral PB injection which also included the caudal part of 
the pedunculopontine nucleus, the retrograde labeling in the BST was 
identical to that seen after injections restricted to the PB. However, 
in this case, numerous retrogradely labeled neurons were observed in 
the medial preoptic area; very few of these cells were double-labeled 
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with the peptides examined here, in agreement with the recent report of 
Swanson et al. ('87). 
Distribution of Immunoreactive Neurons 
Although CRF-, NT- and SS-immunoreactive neurons were previously 
reported in the BST (Swanson et al., '83; Woodhams et al., 1 83; Gray 
and Magnuson, 1 87), their subnuclear organization was not emphasized. 
Neurotensin-immunoreactive (NT-ir) cells were nwnerous in the dorsal 
lateral subnucleus where they formed a discrete oval group coextensive 
with DL. Through successively more caudal sections, this NT-ir group 
moved dorsally to become continuous with NT-ir cells in the supra-
capsular subnucleus. Caudally, NT-ir cells formed a small cluster in 
the medial part of the preoptic BST subnucleus. A few NT-ir cells 
were also found in PL, AM, PS, VH, PI, PM and lateral PO. 
At rostral levels, somatostatin-immunoreactive (SS-ir) cells were 
less numerous than NT-ir cells. They showed a slight concentration in 
DL but were generally scattered throughout PL, AM, PS and along the 
dorsal and ventral surfaces of the anterior commissure. SS-ir neurons 
were especially numerous in the caudal BST subnuclei, particularly in 
the posterior lateral, posterior intermediate and lateral preoptlc 
subnuclei. In PL, they formed a distinct cluster located between the 
internal capsule and the postcommissural stria terminalis. A few SS-ir 
cells were also found amidst the fibers of the receding anterior 
commissure in the intermediate subnucleus. 
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Enkephalin-immunoreactive (ENK-ir) neurons were numerous throughout 
DL with lesser numbers found in VL, PL, SC, AM, and VM. A small
cluster of ENK-ir cells was located rostrally between the parastrial 
nucleus and the ventral lateral subnucleus. Only a few ENK-ir cells 
were found caudal to the crossing of the anterior commissure, and those 
were primarily in PM and PI, 
Corticotropin releasing factor-immunoreactive (CRF-ir) neurons were 
the aost numerous of the four types of peptidergic neurons examined in 
the BST. At rostral levels, CRF-ir cells were concentrated in two 
groups: one, in the dorsal lateral subnucleus, and the other, 
bridging both PS and VL. After the PS-VL split at more caudal levels, 
CRF-ir cells were found in both PS and VL, and in lesser numbers, in AK 
and PL. Kost caudally, CRF-ir cells were located in PM and PL, and, 
most abundantly, in lateral PO. 
Double-labeled neurons 
Retrogradely labeled neurons that also contained either SS-ir, 
CRF-ir or NT-ir (i.e., double-labeled neurons) were most numerous in 
the dorsal lateral BST subnucleus (Figs. 3,4,6-8), particularly after 
injections centered in the external lateral PB subnucleus (Fig. 2A). 
Double-labeled cells in the posterior lateral and ventral lateral BST 
subnuclei were few, and these were often found after injections into, 
respectively, the medial portion of the medial PB (Fig. 2B) and the 
lateral portion of medial PB (Fig. 2C). Two injections which included 
most of the PB subnuclei produced comparable and extensive retrograde 
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labeling in the BST. In these two cases, the retrogradely labeled, 
immunoreactive, and double-labeled neurons in the BST were counted to 
assess the relative contribution of each neuropeptide to the BST-PB 
pathway (Table 1). Cell counts of labeled neurons within the dorsal 
lateral subnucleus were also included in Table 1 since 51, 77 and 84% 
of the cells double-labeled for, respectively, SS-ir, CRF-ir and NT-ir 
were located in the DL subnucleus. The distributions of double-labeled 
cells within the BST subnuclei are depicted in Figures 6-9. These BST 
levels were chosen because they contain the majority of 
neuropeptide-containing cells which project to the PB. 
Corticotropin releasing factor. Cells labeled with both CRF-ir and 
Fast Blue were numerous throughout the dorsal lateral subnucleus (Figs. 
3,6). A few double labeled cells were also found in VL, AL, PL and SC 
(Fig. 6). Fourteen percent of the retrogradely labeled neurons in the 
BST were CRF-immunoreactive (Table 1). Sixteen percent of the CRF-ir 
neurons in the BST, and 33% of the CRF-ir neurons in the dorsal lateral 
subnucleus, were retrogradely labeled (Table 1). Elsewhere in the 
forebrain, retrogradely labeled CRF-ir neurons were located in the 
central nucleus of the amygdala, intercalated nuclei of the amygdala, 
lateral hypothalamus, medial parvocellular paraventricular hypothalamus 
and lateral preoptic area (Moga and Gray, '85b,c,d; Chapters III,V). 
Neurotensin. Many neurons in the dorsal lateral BST subnucleus 
were labeled for both NT-ir and Fast Blue (Figs. 4,7). An occasional 
NT-ir double-labeled cell was also found in the adjacent AL and SC 
(Figs. 4,5,7). Similarly to CRF-ir, 14% of the retrogradely labeled 
neurons in the BST contained NT-ir (Table 1). Twenty percent of the 
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NT-ir cells in the BST, and 34% of the NT-ir cells in the dorsal 
lateral subnucleus, were retrogradely labeled {Table 1). HT-ir 
retrogradely labeled cells were also seen in the central nucleus of the 
amygdala, intercalated nuclei of the amygdala, 1ublenticular substantia 
innominata, preoptic area, medial parvocellular paraventricular 
hypothalamus, lateral hypothalamus, retrochiasmatic area, zona incerta 
and periaqueductal gray (Moga and Gray, '85b,c,d; Chapters III,V). 
Somatostatin. Cells double-labeled for SS-ir and Fast Blue were 
found in DL, AL, PL and SC with a slight concentration in DL (Fig. 8). 
In contrast to CRF-ir and NT-ir, only 4% of the retrogradely labeled 
cells in the BST were SS-ir {Table 1). Fourteen percent of the SS-ir 
neurons in the BST, and 507. of the SS-ir neurons in the dorsal lateral 
subnucleus, were retrogradely labeled (Table 1). Somatostatin-
immunoreactive double-labeled cells were also seen in the central 
nucleus of the amygdala, lateral hypothalamus and medial parvocellular 
paraventricular hypothalamus {Moga and Gray, '85b,d; Chapters III,V). 
Enkephalin. Enkephalin-immunoreactive neurons in the BST were 
never double-labeled with Fast Blue after PB injections even though 
both ENK-ir and retrogradely labeled cells were concentrated in DL 
(Fig. 9). However, double-labeled ENK-ir cells were observed in the 
medial parvocellular paraventricular hypothalamus, and less commonly, 
in the medial preoptic area {Moga and Gray, '85d). 
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DISCUSSION 
The principal finding to emerge from this study is that CRF-ir, 
NT-ir and SS-ir neurons in the lateral BST provide a substantial 
peptidergic input to the parabrachial nucleus, and that ENK-ir neurons 
in the BST do not contribute to this pathway. Similarly, in a previous 
study, we found that neurons in the CeA that project to the PB contain 
CRF-ir, NT-ir and SS-ir but not ENK-ir (Moga and Gray, '85b). Recently 
we have demonstrated that many CRF-ir and NT-ir neurons in the 
perifornical lateral hypothalamus (LH) and retrochiasmatic hypothalamus 
(RCh) project to the PB (Moga and Gray, 85d). The PB also receives 
peptidergic input from NT-ir, CRF-ir and SS-ir neurons in the nucleus 
of the solitary tract (NTS, Mantyh and Hunt, '84; Milner and Pickel, 
'86a; Herbert et al., '87). 
The results from the present study suggest that the BSTL 
projection to the PB is topographically organized. Retrogradely 
labeled neurons in the dorsal lateral BST subnucleus were particularly 
numerous after fast blue injections which included the external lateral 
and central lateral PB subnuclei, whereas, labeled neurons in posterior 
lateral BST neurons were numerous after injections which included the 
medial PB subnucleus. In addition, injections into the waist area of 
the PB produced a comparable amount of retrograde cell labeling in both 
DL and PL. The ventral lateral BST may project to a discrete area 
within the PB; cell labeling in this small BST subnucleua was only 
noted after injections which included the lateral portion of the 
rostral, medial PB subnucleus. As further evidence that the BSTL 
71 
descending pathways are topographically organized, Gray and Magnuson 
('87) found that the BSTL projection to the dorsal vagal complex 
originates largely from the posterior lateral BST. Similarly, the BSTL 
projection to the ventral lateral medulla also arises from a limited 
population of neurons within the BSTL, namely the posterior lateral 
subnucleus (unpublished observations). 
Similarities between CeA and BSTL 
Recently, a number of investigators have presented evidence in 
support of the view that the BSTL and CeA constitute one anatomical 
entity (e.g., DeOlmos et al., '85; Holstege et al., '85). For example, 
a continuum of cells stretching from the BSTL through the sublenticular 
substantia innominata to the CeA is labeled after retrograde tracer 
injections into the dorsal vagal complex (Schwaber et al., '82), raphe 
nuclei (Holstege et al., '85) and parabrachial nucleus (Moga and Gray, 
'85b). Golgi-stained neurons in the lateral BST resemble those found 
in the central nucleus of the amygdala (McDonald, '83); and similar 
neuropeptides are abundant in both the BSTL and CeA (Woodhams et al., 
'83; DeOlmos et al., '85). 
As additional evidence of the close relation between the BSTL and 
CeA, we have found that the BSTL projection to the PB is similar to the 
CeA-PB pathway in a number of respects. Both lateral BST and CeA 
project heavily to the PB, and both pathways terminate in similar PB 
subnuclei (Moga et al., '86). The peptidergic projections from the CeA 
and BSTL to the PB arise from largely circumscribed areas within these 
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nuclei, namely the DL and CeL; these projections have been found to 
stain for identical neuropeptides; and, they terminate primarily within 
the external lateral PB subnucleus (Hoga and Gray, '85b; present 
study). The pathways from the BSTL and CeA to the dorsal vagal complex 
also originate from specific subnuclei (i.e., posterior lateral BST and 
CeH), and also contain similar neuropeptides (Gray and Magnuson, '87). 
These findings would suggest that subdivisions in the CeA (Wray and 
Hoffman, '83; Cassell et al., '86) may have counterparts in the lateral 
BST. In particular, the dorsal lateral BST subnucleus may correspond 
to the lateral subdivision of the CeA, and the posterior lateral BST, 
to CeH (Gray and Magnuson, '87). 
However, differences may exist between the lateral BST and CeA. 
For example, BSTL contains two subnuclei (i.e., the ventral lateral and 
anterior lateral subnuclei) that do not appear to have counterparts in 
the CeA. In particular, the anterior lateral subnucleus resembles both 
DL and PL in its connections and neuropeptides; and yet, its distinct 
Nissl-staining sets its apart from both of these subnuclei and from the 
CeA. Like the other ventral BST subnuclei, the ventral lateral sub-
nucleus is extensively connected with the hypothalamus; in addition, it 
receives heavy input from the CeA, input that is not reciprocated. 
These differences suggest that the BSTL and CeA are not entirely 
homologous. 
Peptide Pathways of BST 
Few studies have examined the BST efferent cell populations for 
their peptide content. Recently, Gray and Magnuson ('87) demonstrated 
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that CRF-, NT-, SS- and substance P-immunoreactive neurons in the BST 
project to the dorsal vagal complex. In this study we have found a 
heavy peptidergic projection to the parabrachial nucleus which also 
originates from the CRF-ir, NT-ir and SS-ir neurons. Besides its 
efferents to the amygdala and brainstem, the BST also projects to the 
hypothalamus (Swanson and Cowan, '79) but the peptides in this 
projection are unknown. 
In contrast, the neuropeptide content of the BST afferent cell 
populations, particularly those in the amygdala, has been studied 
extensively. Using a combination of stria terminalis transections, 
lesions of the amygdala and immunohistochemistry, the amygdala 
projection to the BST has been found to stain for: neurotensin (Uhl et 
al., '78), enkephalin (Uhl et al., '78; Rao et al., '87), substance P 
(Sakanaka et al., '81), vasoactive intestinal polypeptide (VIP, Roberts 
et al., '80b; Eiden et al., '85), somatostatin (McDonald, '87) and 
neuropeptide Y (Allen et al., '84). The BST also receives VIP input 
from the mesencephalon, most probably from the raphe nuclei (Eiden et 
al., '85), and calcitonin gene-related peptide input from the PB 
(Shimada et al., '85). 
Functional Considerations 
The bed nucleus of the stria terminalis is extensively inter-
connected with nuclei, such as the PB, CeA, nucleus of the solitary 
tract and paraventricular hypothalamus, that are involved in central 
cardiovascular regulation (Loewy and McKellar, '80). However, there 
has been little physiological evidence for a cardiovascular role for 
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the BST. Vasodepressor responses have been noted after electrical 
stimulation of the dorsal preoptic hypothalamus; this area may include 
the ventral BST subnuclei (Kabat et al., '35; Hilton and Spyer, '71; 
Faiers et al., '76). In contrast, numerous physiological studies of 
the CeA have been completed. Electrical stimulation of the CeA elicits 
respiratory activation and a pressor response (Galeno and Brody, '83; 
Harper et al., '84). These responses are strikingly similar to those 
obtained from stimulation of the PB (Hraovitch et al., '82; Frysinger 
et al., '84). Thus, the cardiovascular and respiratory responses of 
the CeA may be mediated through its projections to the PB. In light of 
its similarities to the CeA, the BSTL and its projection to the PB may 
also be important in both cardiovascular and respiratory control. 
A few studies have implicated the lateral BST in neuroendocrine 
regulation. For example, in both ovarectomized, estrogen-primed and 
proestrus female rats, electrical stimulation of the lateral BST 
prevents luteinizing hormone discharge and blocks ovulation (Beltramino 
and Taleisnik, '80). In anesthetized rats, electrical stimulation of 
the postcommissural lateral BST results in decreased plasma cortico-
sterone levels (Dunn, '87). These findings are similar to those 
obtained from electrical stimulation of the CeA (Beltramino and 
Taleisnik, '78; Dunn and Whitener, '86), and suggest that the CeA and 
BSTL play similar roles in neuroendocrine regulation. 
Several lines of evidence suggest that the BSTL may be involved in 
fluid and electrolyte balance. Fibers immunoreactive to angiotensin 
II, a potent dipsogen, are numerous within the dorsal part of the BSTL 
(Lind et al., '85). Microinjections (48.6 picomoles) of angiotensin II 
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into this area of the BSTL elicit a drinking response (Swanson and 
Sharpe, '73). Furthermore, the lateral BST is connected with several 
nuclei, including the PB, that have been implicated in fluid 
regulation. For example, rats with bilateral ablations of the external 
lateral PB subnucleus exhibit an exagerrated drinking response after 
systemic administration of angiotensin II (Ohman and Johnson, '86). As 
the dorsal lateral BST sends a dense projection to the external lateral 
pB (unpublished observations), this pathway may possibly relay 
information concerning angiotensin-induced thirst. 
The significance of NT-ir, CRF-ir and SS-ir in BSTL neurons that 
project to the PB is unclear. Hicroinjections of neuropeptides into 
central autonomic nuclei elicit a variety of visceral responses (e.g., 
Kalivas et al., '82; Denavit-Saubie et al., '82). However, there has 
been no study examining the effects of CRF, NT or SS microinjections 
into the PB; such a study may help elucidate the function of these 
neuropeptides in the BSTL-PB pathway. 
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Figure 1. Photomicrographs of 30 micron thick, thionin-stained coronal 
sections through seven levels (rostral to caudal, A-G) of the BST 
illustrating the BST subnuclei. Approximate distance from bregma is 
indicated at the top of each photomicrograph. (ac, anterior 
commissure; AL, anterior lateral subnucleus; AM, anterior medial 
subnucleus; BAC, bed nucleus of the anterior commissure; DL, dorsal 
lateral subnucleus; fx, fornix; ic, internal capsule; IM, intermediate 
subnucleus; JXC, juxtacapsular subnucleus; PI, posterior intermediate 
subnucleus; PL, posterior lateral subnucleus; PM, posterior medial 
subnucleus; PO, preoptic subnucleus; PS, parastrial nucleus; SC, 
supracapsular subnucleus; sm, stria medullaris; st, stria terminalis; 
SV, subventricular subnucleus; VL, ventral lateral subnucleus; VM, 
ventral medial subnucleus). 
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Figure 2. Drawings of representative fast blue injection sites in the 
parabrachial nucleus. Shading indicates the center of each injection 
site and the spread of the fluorescent dye. 
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Figure 3. Composite fluorescent photomicrographs of a coronal section 
through mid-level BST illustrating the distribution of (A) cells 
projecting to the PB, and (B) cells immunoreactive to corticotropin 
releasing factor (CRF). Double-labeled cells (indicated by white 
arrows) were numerous, particularly in the dorsal lateral subnucleus. 
Bar • 100 um. (DL, dorsal lateral subnucleus; AL, anterior lateral 
subnucleus; LV, lateral ventricle; ic, internal capsule). 
82 
83 
Figure 4. Fluorescent photomicrographs of a coronal section through 
the dorsal lateral BST subnucleus illustrating {A) cells retrogradely 
labeled after fast blue injections in the PB, and {B) cells 
immunoreactive to neurotensin. Double-labeled cells {indicated by 
white arrows) were often observed in this subnucleus. Bar • 100 um. 
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Figure 5. Fluorescent photomicrographs of a coronal section through 
the the supracapsular BST subnucleus illustrating (A) cells projecting 
to the PB, and (B) cells immunoreactive to NT. Double-labeled cells 
(indicated by white arrows) were occasionally observed in this 
subnucleus. Cells in SC were characteristically found embedded within 
the ascending fibers of the stria terminalis (st). Bar= 100 um. (ic, 
internal capsule; LV, lateral ventricle). 
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Figure 6. Line drawings of four coronal sections through the BST (A-D
1 
rostral to caudal) illustrating the distributions of Fast Blue (•), 
CRF-immunoreactive (A) and double-labeled (*) cells found with the BST 
and adjacent preoptic nuclei after Fast Blue injections into the PB. 
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Figure 7. Line drawings of four coronal sections through the BST (A-D, 
rostral to caudal) illustrating the distributions of Fast Blue (A), 
NT-immunoreactive (6) and double-labeled (*) cells found with the BST 
and adjacent preoptic nuclei after Fast Blue injections into the PB. 
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Figure 8. Line drawings of four coronal sections through the BST (A-D, 
rostral to caudal) illustrating the distributions of Fast Blue (•), 
SS-immunoreactive (6) and double-labeled (*) cells found with the BST 
and adjacent preoptic nuclei after Fast Blue injections into the PB. 
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Figure 10. Line drawings of four coronal sections through the BST 
(A-D, rostral to caudal) illustrating the distributions of Fast Blue 
(A) and ENK-immunoreactive (A) cells found within the BST and adjacent 
preoptic nuclei after Fast Blue injections into the PB. Note the lack 
of double-labeled cells in the BST. 
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Table 1. Number and Percent of lm•unoreactive. Retrogradely Labeled 
and Double-labeled Cella in the Bed Nucleu1 of the Stria Terminali• 
Number of 
I11munoreactive 
Cella 
peptide Total ot1 
cu 
NT 
SS 
1277 
1085 
606 
467 
558 
84 
Number of 
Retrogradely 
Cella 
Total Dt1 
Number of 
Double-labeled 
Celli 
Total Dt 1 
1440 
1651 
1845 
558 201 
667 223 
15' 
188 
42 687 83 
Percent of 
Immuuoreactive 
Celli 1n DL 
Projecting to PB 
33 
34 
50 
1. Number of cell• in the doraal lateral BST 1ubnucleu1. 
Percent of 
Total 
Pathway 2 W/peptlda 
14 
14 
4 
z. percent of total retrogradely labeled cell• ataining for a neuropeptide. 
CHAPTER V 
PEPTIDERGIC PATHWAYS FROM THE HYPOTHALAMUS 
TO THE PARABRACHIAL NUCLEUS 
INTRODUCTION 
Physiological studies have shown that the hypothalamus is able to 
influence autonomic reflexes through its projections to autonomic 
nuclei in the brain stem and spinal cord (Zerihun and Harris, '83; 
Rogers and Nelson, '84; Lawrence and Pittman, 1 85). The hypothalamic 
projection to the parabrachial nucleus (PB) in the pons is particularly 
dense and extensive. Through this pathway, the hypothalamus may 
modulate a number of visceral functions associated with the PB, 
including: fluid regulation (Ohman and Johnson, '86), micturition 
(Lumb and Morrison, '87), and cardiovascular (Mraovitch et al., '82) 
and respiratory (Cohen, '71) responses. 
The hypothalamic projection to the parabrachial nucleus arises 
from a number of nuclei including the paraventricular, lateral, 
dorsomedial, arcuate and preoptic nuclei (Conrad and Pfaff, '76; 
Swanson, '77; Saper et al., '79; Hosoya and Matsushita, '81; Berk and 
Finkelstein, '82; Saper and Levisohn, '83; Takeuchi and Hopkins, '84; 
Chiba and Murata, '85; Luiten et al., '85; Milner and Pickel, '86a). 
Regarding its neuropeptide content, neurotensin- and substance P-
immunoreactive neurons in the paraventricular and lateral hypothalamus 
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1iave been found to project to the PB (Milner and Pickel, '86a,b). 
•triopeptin-immunoreactive neurons in the anteroventral periventricular 
aucleus of the hypothalamus also innervate the PB (Saper et al., '85). 
Ho•ever, the hypothalamus contains neurons which are immunoreactive to 
a number of other neuropeptides, some of which are also present in 
fibers within the PB, these include: angiotensin II (Lind et al., 
'SS), dynorphin (Khachaturian et al., '82), alpha-melanocyte 
itimulating hormone (O'Donohue et al., '79), corticotropin releasing 
factor (Swanson et al., '83), somatostatin (Finley et al., '81), 
enkephalin (Simantov et al., '77), galanin (Rokaeus et al., '84) and 
vasopressin (Sofroniew, '80). Because some of these neuropeptides may 
be present in the hypothalamic projection to the PB, this experiment 
examines the PB afferent cell populations in the hypothalamus for their 
neuropeptide content using the combined retrograde fluorescence-
itUDunohistochemical method. Preliminary findings of this study were 
previously reported (Hoga and Gray, '85d). 
METHODS 
Thirty male Long-Evans rats (250-350g) were used in this study. 
Each animal was anesthetized with 7% chloral hydrate. Injections 
(50-100 nl) of 2% fast blue (D. R. !ling) were made into the 
parabrachial nucleus with a 1.0 ul Hamilton syringe fitted with a glass 
•icropipette. Injections were made over a 15-minute period, and the 
Pipette was left in place for an additional 10 minutes. After 11-13 
days survival, the animals were treated with 150-160 ug colchicine 
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(Sigma) in 10 ul saline injected into the lateral ventricle. 
Thirty-six to 48 hours later, the animals were reanesthetized with 
chloral hydrate and then perfused through the heart with O.OlM 
phosphate-buffered saline (pH 7.6, 37°C) followed by O.lM phosphate-
o buffered 4% paraformaldehyde (pH 7.6, 4 C). After perfusion, the skull 
was placed in a stereotaxic frame (Kopf), and the brain was sliced into 
coronal blocks. The blocks of brain tissue were post-fixed in 4~ 
paraformaldehyde for 30 minutes to 2 hours and then cut serially on a 
vibratome (Lancer). Sections from the injection site (40 um) were 
mounted onto chrom-alum-coated slides. Adjacent coronal sections 
(20 um) of the forebrain were collected in four vials of cold 
phosphate- buffered saline (PBS). Each series of adjacent sections was 
rinsed in PBS for 20 minutes and then placed in a primary antiserum 
with gentle agitation for 14-24 hours in a cold room (4°c). Next, the 
sections were rinsed in PBS for 20 minutes and then incubated in the 
secondary antibody, biotinylated goat anti-rabbit IgG (Bethesda 
Research Laboratory), for 30 minutes at room temperature, rinsed again 
in PBS for 15 minutes, and then incubated in streptavidin-Texas Red 
conjugate (Bethesda Research Laboratory) for 30 minutes. In a few, 
early experiments, the secondary antibody used was a rhodamine-
conjugated goat antirabbit IgG (Cooper Biomedical, diluted 1:10 in 
PBS-Triton-X). With this antibody, sections were reacted at 45°c for 
10 minutes and then at room temperature for 60 minutes. The biotin-
avidin-Texas Red complex proved to be more consistent in staining and 
more resistant to fading than the rhodamine, and so was used in later 
experiments. Following incubation in secondary antibody, sections were 
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transferred to cold PBS, mounted onto chrom-alum-coated slides, and 
coverslipped with DePeX (BDH Chemicals). 
The following primary antisera were used (name, lot and bleed 
number, source, and reference in which the antisera was previously 
characterized): anti-corticotropin releasing factor (#465) provided by 
nr. T.L. O'Donohue (Olschowka et al., '82); anti-angiotensin II (CD3) 
provided by Dr. C.F. Deschepper (Deschepper et al., '86); anti-
dynorphin (#54 bleed 6), anti-MSH, anti-adrenocorticotropin (#23 bleed 
1), anti-arg-vasopressin (#48 bleed 10) and anti-oxytocin (#48 bleed 
10), provided by Dr. S.J. Watson (Watson and Akil, 1 80; Watson et al., 
'78, '82); anti-somatostatin (#8535027) and anti-neurotensin 
(#8351022), obtained from the Immunonuclear Corporation (Kohler and 
Chan-Palay, '82; Beitz, '82); anti-met-enkephalin, provided by Dr. R. 
Elde (Haber and Elde, '82); and anti-galanin, obtained from Peninsula 
Labs (Skofitsch and Jacobowitz, '85). Antibody specificity was tested 
by incubating colchicine-treated sections of the hypothalamus in l ml 
of diluted antibody preincubated for one hour with 25-50 ug of its 
respective peptide. No immunohistochemical staining was observed in 
these controls. The antisera were diluted 1:500 (SS, ENK, DYN, NT, 
AII, ACTH, MSH), 1:1000 (GAL), 1:2000 (CRF), and 1:5000 (OXY, AVP) in a 
solution containing PBS, 0.1% Triton-X-100 (Mallinckrodt) and 1% normal 
goat serum. 
The material was examined with an Olympus microscope equipped with 
a lOOW mercury light source. Fast blue was visualized with an 
excitation wavelength centered at 330-360 nm (Olympus ultraviolet 
filter system). Texas Red immunofluorescence was viewed with the 
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Olympus green (546 nm) filter system. Cells that contained both 
retrograde fluorescence and imaunofluorescence were detected by 
switching between filter systems. Sections were photographed with 
polaroid coaterless land pack film 667, ASA 3000. Sections were 
plotted with a Leitz Orthoplan microscope (filter systems A and NZ) 
equipped with digital stage position readout heads (Minnesota 
l)atametrics, MD-1). The x- and y-coordinates of the labeled neurons 
were recorded by a Rockwell AIM 65 microcomputer and then plotted onto 
an x-y plotter. After plotting, the slides were soaked in xylene to 
remove the coverslips and then counterstained with thionin to determine 
the subnuclear location of the labeled cells. 
RESULTS 
Distribution of Retrogradely Labeled Neurons 
After Fast Blue injections into the parabrachial nucleus, 
retrogradely labeled neurons were observed throughout the forebrain in 
nuclei previously shown to project to the PB (e.g., central nucleus of 
the amygdala, bed nucleus of the stria terminalis). These afferent 
cell populations are described in detail in other studies (Moga and 
Gray, '85b,c; Moga et al., in preparation). Within the hypothalamus, 
retrogradely labeled neurons were particularly numerous after 
injections into the rostral half of lateral PB (Fig. lA,B). After a 
typical PB injection (Fig. lB), many retrogradely labeled cells were 
observed rostrally in the median preoptic nucleus. The anteroventral 
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periventricular nucleus (AVPV), as defined by Simerly et al., '84, 
contained a few labeled cells. A few neurons were located in the 
medial preoptic nucleus, primarily along its lateral border. In 
contrast, labeled neurons were frequently found in the lateral preoptic 
area. Many retrogradely labeled cells were located in the retro-
chiasmatic area (RCh, e.g., Fig. 7). Labeled cells in RCh appeared 
continuous with those in the arcuate nucleus and ventrolateral parts of 
the ventromedial hypothalamus. In the paraventricular hypothalamus 
(PVH), cells were found predominantly in the medial and lateral 
parvocellular subdivisions with a few scattered cells in the anterior 
and dorsal parvocellular, and posterior magnocellular subdivisions 
(e.g., Fig. 14). caudal to the PVH, labeled neurons arched over the 
fornix to form a particularly dense cluster in the lateral hypothalamus 
(LH) between the fornix and the internal capsule (Fig. 8). This 
cluster separated at more caudal levels into a perifornical group and a 
capsular group of cells. Labeled cells in the capsular LH group 
extended to the most caudal levels of the hypothalamus where they 
surrounded the internal capsule and adjacent subthalamus {Fig. 8). The 
perifornical LH group, with successively caudal sections, moved 
medially to become continuous with cell labeling in the dorsal hypo-
thalamic area {DH) dorsal to the dorsomedial nucleus {Fig. 8). Only a 
few retrogradely labeled neurons were found ventrally in the LH. 
Medially, labeled cells were seen in the diffuse portion of the dorso-
medial hypothalamus (DMH, Fig. 13). 
A slightly different pattern of hypothalamic labeling was noted 
after fast blue injections into the caudal 'waist' area of the PB 
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(Fig. le). In these cases (e.g., Fig. 17), retrograde labeling in the 
hypothalamus appeared more discrete and less numerous than after 
rostral PB injections. In particular, labeled cells in perifornical LH 
were less numerous and did not form a dense cluster. In contrast, 
retrogradely labeled cells in capsular LH were more numerous and formed 
a dense 'cap' surrounding the subthalamus. In all cases, retrogradely 
labeled neurons were found bilaterally but with a heavy ipsilateral 
dominance. 
Distribution of Immunoreactive Neurons 
The distributions of neuropeptide-immunoreactive neurons in the 
hypothalamus were similar to those described in a number of immuno-
cytochemical studies (Uhl et al., '79; Uhl and Snyder, '81; Sofroniew, 
'80; Swanson et al., '83; Lind et al., '85; Finley et al., '81; 
Khachaturian et al., '82; Watson et al., '78; Watson and Akil, '80; 
Skofitsch and Jacobowitz, '85); therefore, I will only briefly describe 
my findings. 
Oxytocin-immunoreactive (OXY-ir) and vasopressin-immunoreactive 
(AVP-ir) cells were confined to the PVH, supraoptic and accessory 
magnocellular nuclei. In the PVH, OXY-ir cells were found in all three 
magnocellular subdivisions whereas AVP-ir cells were concentrated in 
the core of the posterior magnocellular subdivision (Figs. 14,15). 
Many OXY-ir and AVP-ir cells were also found in the parvocellular 
subdivisions of the PVH. 
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~orticotropin releasing factor-immunoreactive (CRF-ir) neurons 
were prominent in the dorsal part of the medial parvocellular PVH 
subdivision (Fig. 11). Caudal to the PVH, CRF-ir neurons were numerous 
in the LH, particularly dorsal and lateral to the fornix. A few CRF-ir 
neurons were also present in the retrochiasmatic area and dorsal 
hypothalamic area. Neurotensin-immunoreactive {NT-ir) neurons were 
found in the dorsal and medial parvocellular, and periventricular 
subdivisions of the PVH (Fig. 10). NT-ir neurons were numerous in the 
retrochiasmatic area where they extended laterally over the optic 
tract. In the LH, NT-ir neurons were concentrated dorsal and lateral 
to the fornix with a few also present ventral and lateral to the 
fornix. Most caudally, NT-ir cells were found in the dorsomedial part 
of VMH and in the arcuate nucleus. 
In the PVH, galanin-immunoreactive (GAL-ir) neurons were most 
numerous in the posterior magnocellular and medial parvocellular 
subdivisions (Fig. 12). Many GAL-ir neurons were found in LH, 
particularly dorsal and lateral to the fornix, and ventrally along the 
brain surface. The DMH contained the heaviest concentration of GAL-ir 
cells. GAL-ir neurons were also found in RCh, ARC and DHA. A moderate 
number of angiotensin II-immunoreactive (AII-ir) neurons were present 
in both magnocellular and parvocellular PVH as well as in RCh (Fig. 9). 
AII-ir cells in the LH were concentrated dorsal and medial to the 
fornix; these cells appeared continuous with AII-ir cells in the DH 
and diffuse portion of the DMH. The arcuate nucleus also contained a 
few AII-ir cells. 
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Dynorphin-immunoreactive (DYN-ir) neurons were concentrated in 
•agnocellular PVH with lesser numbers in parvocellular PVH and SO (Fig. 
s). DYN-ir neurons were numerous in the lateral hypothalamus, 
particularly dorsal and medial to the fornix. Concentrations of DYN-ir 
neurons were also found along the ventral lateral surface of the 
hypothalamus, and at rostral LH levels, dorsal to the supraoptic 
nucleus. Met-enkephalin-immunoreactive (ENK-ir) neurons were numerous 
in the paraventricular nucleus, primarily in its parvocellular 
subdivisions (Fig. 7). Caudal to the PVH, ENK-ir neurons were 
especially common medially and ventrally in the hypothalamus, 
particularly in the arcuate and ventromedial nuclei, and along the 
ventral surface of the hypothalamus. ENK-ir cells were notably absent 
in the dorsal and lateral portions of the lateral hypothalamus. 
Somatostatin-immunoreactive (SS-ir) neurons in the PVH were 
concentrated rostrally in the periventricular subdivision (Fig. 13). 
Caudal to PVH, SS-ir neurons were numerous medially and ventrally in 
the hypothalamus; these neurons encircled the VMH. A few SS-ir cells 
were found in DMH, ARC and LH. 
Adrenocorticotropin-immunoreactive (ACTH-ir) neurons were 
restricted to the arcuate nucleus and retrochiasmatic area (Fig. 17). 
In contrast, melanocyte stimulating hormone-immunoreactive (MSH-ir) 
neurons were more widespread in the hypothalamus, occurring in the 
arcuate nucleus, RCh and lateral hypothalamus (Fig. 16). 
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D .• rnble-labeled Neurons 
Double-labeled neurons were most numerous after injections into 
the rostral lateral PB. In one case per neuropeptide, the retrogradely 
labeled, immunoreactive, and double-labeled neurons in the hypothalamus 
were counted to assess the relative contribution of each neuropeptide 
to the hypothalamic-PB pathway. In these cases, the injection site 
included most of the parabrachial nucleus. Cell counts were restricted 
to the PVH, perifornical LH, RCh and the arcuate nucleus as these 
nuclei were previously shown to contain the majority of double-labeled 
cells (Moga and Gray, '85d). Perifornical LH was defined as that area 
around the fornix which contained a concentration of neuropeptide- like 
lmmunoreactive cells. The retrochiasmatic area was defined as that area 
in the ventrobasal hypothalamus which is caudal to the optic chiasm and 
rostral to the caudal boundaries of PVH. The distributions of double-
labeled cells within the hypothalamus are depleted in Figures 7-17. 
The hypothalamic levels chosen for these figures best represent the 
double-labeling seen for each peptide. 
Paraventricular Hypothalamus. A few double-labeled cells were 
found in the PVH for most of the peptides examined. ENK-ir cells were 
the most numerous among those double-labeled in the PVH, accounting for 
approximately 2% of PVH neurons projecting to PB (Fig. 7). These 
!NK-ir double-labeled neurons were concentrated in the medial 
parvocellular subdivision of PVH. DYN-ir double-labeled neurons showed 
a similar distribution to those of ENK-ir but were fewer in number; 
approximately 1% of the retrogradely labeled cells in the PVH contained 
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DYN-ir (Fig. 8). Fewer than 1% of the Fast Blue labeled cells in the 
pVH contained either AII-ir, NT-ir, CRF-ir, GAL-ir or SS-ir (Figs. 
9,10,11,12,13). Somatostatin-immunoreactive neurons, vhen double 
labeled, were found adjacent to the caudal periventricular concentra-
tion of SS-ir neurons in PVH (Fig. 13). Oxytocin-ir double-labeled 
cells were typically found in the lateral parvocellular subdivision in 
low numbers (<1%) after lateral PB injections (Fig. 14). AVP-ir 
double-labeled neurons were occasionally seen (<1%), particularly after 
'waist' injections in PB. A few AVP-ir double-labeled cells were large 
eagnocellular neurons which were lightly, though distinctly, labeled 
with Fast Blue (Fig. 15). Cells labeled for both MSH-ir and Fast Blue 
were never found in the PVH but were often located just outside the PVH 
(Fig. 16). 
Retrochiasmatic Area. Double-labeled neurons were frequently seen 
in RCh. DYN-ir cells were the most numerous, accounting for approx-
imately 3% of the RCh neurons with projections to the PB (Fig. 8). 
About 1% of the retrogradely labeled neurons in RCh stained for NT-ir, 
and these were located primarily in the lateral part of RCh (Fig. 10). 
In contrast, AII-ir double-labeled cells, also representing approx-
imately 1% of the RCh-PB projection, were concentrated in the medial 
part of RCh (Fig. 9). Cells containing both Fast Blue and either 
GAL-ir or CRF-ir were few (less than 1%; Figs. 11,12). The majority of 
double-labeled cells in the RCh were round and medium-sized, and 
resembled proopiomelanocortin-containing cells. 
Lateral Hypothalmus. Many double-labeled neurons were located in 
the perifornical region of LH. Thirty percent of the retrogradely 
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labeled cells in perifornical LH contained DYN-ir. DYN-ir double-
labeled cells were particularly numerous dorsomedial to the fornix with 
only an occasional cell ventrolateral to the fornix (Fig. 8). AII-ir 
double-labeled cells showed a similar distribution to DYN-ir (Fig. 9) 
but were fewer in number - about 201. of the retrogradely labeled cells 
in LH contained AII-ir. Both CRF-ir and NT-ir double-labeled neurons 
were common dorsolateral to the fornix with a few cells found below the 
fornix and adjacent to the internal capsule (Figs. 10,11). Their 
contributions to the perifornical LH-PB projection were 201., CRF-ir, 
and 251., NT-ir. Cells labeled for both GAL-ir and Fast Blue (51.) were 
concentrated in the dorsolateral perifornical LH (Fig. 12). Double-
labeled GAL-ir neurons were also found scattered below the fornix and 
near the internal capsule. Double-labeled MSH-ir neurons were unique 
in their LH distribution for showing a particularly heavy concentration 
near the internal capsule (Fig. 16). Twenty-two percent of the 
retrogradely labeled cells in capsular LH stained for MSH-ir. Only a 
few MSH-ir double-labeled cells were located in perifornical LH. 
Finally, less than 11. of the retrogradely labeled neurons in LH 
contained either SS-ir or ENK-ir (Figs. 7,13). 
Arcuate Nucleus. Neurons double-labeled for Fast Blue and a 
proopiomelanocortin-related peptide were frequently seen in the arcuate 
nucleus (Figs. 16,17). Seventy-one percent of the retrogradely labeled 
neurons in ARC were ACTH-immunoreactive. Cells labeled with both 
MSH-ir and Fast Blue were also numerous within the arcuate nucleus, 
accounting for approximately 491. of the ARC-PB projection. In 
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addition, an occasional DYN-ir or NT-ir double-labeled cell was also 
found in ARC (Figs. 8,10). 
Other Hypothalamic Nuclei. Double-labeled cells in the preoptic 
area were rarely seen. The distributions of cells containing CRF-ir, 
NT-ir and ENK-ir in the preoptic area were depicted in Chapter IV 
(Fig. 5) of this dissertation. GAL-ir double-labeled cells in the 
lateral preoptic area were the most consistently seen, followed by 
NT-ir cells in LPO and the median preoptic nucleus (Fig. 2). Less 
frequently, a CRF-ir or ENK-ir double-labeled cell was observed in the 
medial preoptic area. After one injection which included the central 
gray matter, a few NT-ir neurons in the medial preoptic area were 
lightly labeled with Fast Blue. 
Few retrogradely labeled cells were seen within the ventromedial 
nucleus of the hypothalamus, and of these, still fewer were double-
labeled. In one case, ENK-ir neurons in the ventral lateral VMH were 
lightly labeled with Fast Blue, probably as a result of tracer spread 
to the central gray. In the dorsomedial hypothalamus, an occasional 
small GAL-ir or AII-ir neuron was double-labeled (Figs. 9,12). More 
often, immunoreactive neurons dorsal to DMH, in the dorsal hypothalamic 
area (DH), contained Fast Blue. Double-labeled cells in DH included 
DYN-ir, AII-ir and CRF-ir, and less frequently, ENK-ir and SS-ir (Figs. 
7,8,9,11,13). 
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DISCUSSION 
Hypothalamic Peptidergic Pathways to PB 
The results from the present study demonstrate that PB afferent 
cell populations in the hypothalamus contain a wide variety of neuro-
peptides. Based on the eleven antisera used in this study, most of the 
neuropeptide-immunoreactive neurons projecting to the PB were concen-
trated in the perifornical LH, retrochiasmatic area, paraventricular 
hypothalamus and arcuate nucleus. 
In the perifornical lateral hypothalamus, a significant percentage 
of the neurons projecting to the PB stain for CRF-ir (20%), NT-ir 
(25%), AII-ir (20%), and DYN-ir (30%). A smaller percentage stain for 
GAL-ir (5%), SS-ir (<1%) and ENK-ir (<1%). In the caudal lateral 
hypothalamus (i.e., capsular LH), 22% of the retrogradely labeled 
neurons contained MSH-ir. Very few other double-labeled cells were 
noted in this portion of LH. Previous studies have shown that neurons 
contributing to the LH-PB pathway also stain for substance P (SP-ir)-
and atrial natriuretic polypeptide (ANP-ir)-immunoreactivity (Saper et 
al., '85; Milner and Pickel, '86b). 
Neuropeptide-immunoreactive neurons in both perifornical and 
capsular LH project to a number of other brain nuclei. In a recent 
study, Cechetto and Saper ('88) examined the peptide content of the LH 
projection to the spinal cord using a similar set of antisera. After 
Fast Blue injections into the spinal cord (SC), they found retrogradely 
labeled neurons in perifornical LH that stained for NT-ir (few), SP-ir 
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(few), GAL-ir (few), DYN-ir (25%) and ANP-ir (20%). In capsular LH, 
95% of the retrogradely labeled neurons stained for MSH-ir. No 
retrogradely labeled CRF-ir neurons were found in LH in this study. 
Co•paring data from these two studies demonstrates that the types and 
percentages of neuropeptide-immunoreactive neurons contributing to 
these two LH pathways may be distinct. These anatomical studies offer 
evidence that different LH pathways may have different peptide 
compositions. 
Other immunohistochemical findings suggest that each neuropeptide 
cell population in LH projects to a number of different nuclei. For 
example, dynorphin-like immunoreactive neurons in perifornical LH 
project to the spinal cord, dorsal vagal complex, periaqueductal gray, 
PB, central nucleus of the amygdala and entorhinal area (Kohler et al., 
'84; Cechetto and Saper, '88; Zardetto-Smith et al., '85; present 
study). In addition, MSH-ir neurons in LH are retrogradely labeled 
after injections in the PB, spinal cord, inferior colliculus, CAl, 
entorhinal area and cortex (Kohler et al., 1 84; Shiosaka et al., '85; 
Saper et al., '85; Cechetto and Saper, '88; present study). 
Neuropeptide-immunoreactive neurons in LH may send collaterals to two 
or more target nuclei. In a recent study, Veening et al. ('87) found 
that about 50% of LH neurons projecting to the PB also project to the 
dorsal vagal complex. 
Less that 2% of the retrogradely labeled cells in the PVH stained 
for either AVP-ir, OXY-ir, NT-ir, CRF-ir, AII-ir, SS-ir, GAL-ir, 
DYN-ir, or ENK-ir. Neuropeptides have previously been demonstrated in 
PVH pathways to the dorsal vagal complex (DVC) and spinal cord. A high 
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percentage of neurons in the PVH that project to the spinal cord stain 
for either AVP-ir (l5%) or OXY-ir (25%) (Cechetto and Saper, '88). In 
contrast, very few (<1%) OXY-ir and AVP-ir double-labeled cells were 
seen after PB injections. Similarly, only a few AVP-ir and OXY-ir 
neurons were retrogradely labeled after DVC injections (Sawchenko and 
Swanson, '82); however, the numbers in this study may have been higher 
with colchicine treatment. The PVH projection to the SC also includes 
GAL-ir (few), SP-ir (few), NT-ir (few), CCK-ir (few) and ENK-ir (10%) 
neurons but not DYN-ir, CRF-ir or SS-ir neurons, whereas the PVH-PB 
projection originates from all of these neuropeptide-immunoreactive 
neurons except for CCK-ir. Of the few neuropeptides examined in the 
PVH-DVC pathway, only small numbers of SS-ir and ENK-ir neurons were 
double-labeled. The PVH peptidergic pathways to the brainstem and 
spinal cord are similar in their neuropeptide compositions and in their 
small percentages of double-labeled cells. 
Neurons in the retrochiasmatic area were recently shown to project 
to the PB, and a few were found to contain NT-ir (Milner and Pickel, 
'86a). In the present study, many ACTH-ir, MSH-ir, DYN-ir and AII-ir, 
and a few GAL-ir and CRF-ir neurons in the RCh were retrogradely 
labeled after a PB injection. In contrast, the RCh projection to the 
spinal cord contains MSH-ir but not GAL-ir, NT-ir, CRF-ir or DYN-ir 
(Cechetto and Saper, '88). In addition, RCh neurons also project to 
the dorsal vagal complex (Swanson and Kuypers, '80) but the peptide 
content of this pathway ia unknown. 
Immunohistochemical studies have previously shovn that cells 
immunoreactive for the proopiomelanocortin (POMC) derived peptides 
112 
(e.g., beta-endorphin, alpha-HSH, ACTH) are present in the ARC and NTS 
of the rat (O'Donohue et al., '79; Joseph et al., '83). There is also 
a population of neurons in LH and zona incerta which stain for the 
HSH-like peptide but not for any other POHC peptide; the HSH-like 
peptide in these cells apparently arises from an unknown biosynthetic 
mechanism (Watson and Akil, '80). By tracing descending POHC fibers 
from the arcuate nucleus, investigators surmised that at least some of 
the POHC fibers in the PB arise from the ARC (Khachaturian et al., 
'84). The present study demonstrates a projection from the ARC to the 
PB. Furthermore, 71% of the retrogradely labeled cells in ARC contain 
ACTH-ir, and 49% contain HSH-ir. As the POHC derived peptides are 
colocalized in the same arcuate neurons (Watson et al., 1 78; Sofroniew, 
'79; Watson and Akil, '80), one would expect these percentages to more 
closely approximate each other. This discrepancy may be due to 
different PB injection sites; the injection site for the HSH-ir cell 
count was located in rostral lateral PB, whereas that for ACTH-ir was 
centered in the caudal 'waist' of PB. Possibly, the ARC projection to 
the PB may be topographically organized. 
Other Peptidergic Afferents of the PB 
In addition to the peptidergic pathways described here, the PB 
also receives a dense CRF-ir, NT-ir and SS-ir input from both the 
central nucleus of the amygdala and the bed nucleus of the stria 
terminalis (Hoga and Gray, '85a,b). Many different neuropeptide-
immunoreactive neurons in the nucleus of the solitary tract project to 
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the PB; these include CRF-ir, NT-ir, SS-ir, CCK-ir, GAL-ir, AII-ir, 
ENK-ir, SP-ir and neuropeptide Y-immunoreactive neurons (Hantyh and 
Hunt, '84; Milner and Pickel, '86a,b; Herbert et al., '87). 
Enkephalin- and dynorphin-immunoreactive neurons in both the spinal 
cord and the spinal trigeminal nucleus project to the PB (Standaert et 
al., '86a). Recently, we have noted double-labeled NT-ir and SP-ir 
neurons in the periaqueductal gray matter after PB injections 
(unpublished observations). 
These peptidergic afferents may be topographically distributed 
within the PB. Recently, we found that afferents to the PB terminate 
in specific PB subnuclei (Moga et al.,'86; Herbert and Saper, 
unpublished observations). For example, both the NTS and CeA project 
heavily to the external lateral and waist PB subnuclei. In contrast, 
hypothalamic nuclei terminate almost exclusively in the central lateral 
and dorsal lateral PB subnuclei. The peptidergic inputs from the CeA 
and NTS would converge in the PB, whereas those from the hypothalamus 
and CeA would be largely segregated. This biochemical specificity and 
topographical distribution of input to the PB may provide a substrate 
for the diversity of visceral responses associated with the PB. 
Functional Considerations 
A variety of adaptive behaviors can be elicited by electrical and 
chemical stimulation of the hypothalamus, including feeding, drinking, 
defense, mating and exploratory behavior (e.g., Folkow and Rubinstein, 
'65; Mogensen and Stevenson, '67; Hoebel, '69; Pfaff, 1 80; Grossman et 
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al., '78; Yardley and Hilton, '86). Some of these behaviors or 
fractional components of them can also be elicited from the PB (Coote 
et al., '73; Micco, '74; van der Kooy, '79; Yardley and Hilton, 1 86). 
This suggests that the hypothalamic projections to the PB may be an 
essential part of the anatomical substrate underlying the complex 
behaviors evoked from the hypothalamus. 
For example, the projections from the lateral hypothalamus to the 
PB may mediate the feeding and drinking responses of the LH. Following 
injections of [ 14cJ-deoxyglucose into freely moving rats, Roberts ('80) 
electrically stimulated the lateral hypothalamus at sites which 
elicited gnawing, eating and drinking. Autoradiographic analysis of 
these rat brains revealed a heavily labeled descending pathway which 
traveled through the lateral tegmentum to terminate in the parabrachial 
nucleus, suggesting that the LH-PB pathway is metabolically active 
during feeding and drinking. Similarly, the PVH projection to the PB 
may be important in norepineprine-induced feeding responses. 
Injections of either norepinephrine (NE) or clonidine (CLON) into the 
PVH have been shown to elicit a robust feeding response in satiated 
rats (Leibowitz, '78, '80). To determine the course of PVH fibers 
mediating this response, Weiss and Leibowitz ('85) made a series of 
coronal knife cuts in the diencephalon and lower brainstem. Rats that 
sustained damage in either the periventricular gray area of the caudal 
thalamus and midbrain or the dorsal lateral part of the caudal pons did 
not respond to injections of either NE or CLON into the PVH, suggesting 
that fibers mediating this response travel through the periventicular 
gray to the PB in the dorsal lateral pons. 
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Defense behavior consists of both autonomic and behavioral 
components (Abrahams et al., '60,'64; Hilton and Zbrozyna, '63). This 
behavior can be elicited from a number of nuclei in the hypothalamus 
and brainstem (for review, Yardley and Hilton, 1 86), many of which 
project to the PB. However, electrical stimulation of the PB evokes 
only part of the defense autonomic component; specifically, the 
hind-limb vasodilation characteristic of the defense reaction is absent 
following PB stimulation (Coote et al., '73; Mraovitch et al., '82). 
Furthermore, the behavioral response (i.e., flight or fight) that is 
typical of the defense reaction has not been reported for the PB. 
Whether the hypothalamic projection to the PB mediates part of the 
autonomic response of the defense reaction remains to be studied. 
The role of neuropeptides in hypothalamic pathways to the PB is 
unknown. Neuropeptides are concentrated in autonomic structures such 
as the hypothalamus, CeA, BST, PB, NTS and midbrain central gray 
(Pickel, '85). Microinjections of neuropeptides into central autonomic 
nuclei elicit a variety of visceral responses (e.g., Kalivas et al., 
'82; Denavit-Saubie et al., '82). However, few studies have 
specifically examined the role of neuropeptides in the PB. In one 
study, the application of the opioid agonists, FK-33824 and DADLE, to 
the rostral dorsal surface of the pons caused a significant decrease in 
respiratory frequency; this effect was attributed to opioid diffusion 
to the medial PB (Burle et al., '85). More conclusively, 
Denavit-Saubie et al. ('78) found that opioid agonists depress the 
spontaneous firing activity of respiratory-related neurons in the 
medial PB. Possibly, the projection from ENK-ir neurons in the PVH to 
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the pB, noted in the present study, 11ay mediate these effects. Clearly 
•ore studies are needed before any conclusions can be drawn as the role 
of neuropeptides in the PB. 
117 
Figure 1. Drawings of representative Fast Blue injection sites in the 
parabrachial nucleus. Shading indicates the center of each injection 
site and the spread of the fluorescent dye. 
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Figure 2. Fluorescent photomicrographs of a coronal section the median 
preoptic nucleus illustrating the distribution of (A) cells projecting 
to the PB (FB), and (B) cells immunoreactive to neurotensin (NT). One 
double-labeled cells is indicated by the white arrow. Bar = 100 um. 
(3V, third ventricle). 
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Figure 3. Fluorescent photomicrographs of a coronal section through 
the caudal half of the paraventricular hypothalamus illustrating (E) 
cells retrogradely labeled after fast blue injections in the PB, and 
(F) cells immunoreactive to oxytocin (OXY). An OXY double-labeled cell 
(white arrow) is indicated in the lateral parvocellular subdivision. 
Bar • 100 um. 
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Figure 4. Fluorescent photomicrographs of a coronal section through 
the paraventricular hypothalamus illustrating (A) cells projecting to 
the PB, and (B) cells immunoreactive to corticotropin releasing factor 
(CRF). Parts C (fast blue-labeled cells) and D (CRF-ir cells) are high 
power photomicrographs of one double-labeled cell (indicated by white 
arrow) found within the medial parvocellular subdivision. Bar • 100 um. 
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Figure 5. Fluorescent photomicrographs of a coronal section through 
the lateral hypothalamus illustrating (A) cells projecting to the PB, 
and (B) cells immunoreactive to neurotensin (NT). Four double-labeled 
cells are indicated by white arrows ventrolateral to the fornix (fx). 
Bar • 100 um. 
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Figure 6. Fluorescent photomicrographs of a coronal section through 
the perifornical area of the lateral hypothalamus illustrating (A) 
cells projecting to the PB, and (B) cells immunoreactive to dynorphin 
(DYN). Six double-labeled cells (indicated by white arrows) are 
located dorsolateral to the fornix (f). Bar • 100 um. 
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Figure 7. Line drawings of coronal sections through four levels of the 
hypothalamus (A-D, rostral to caudal) illustrating the distributions of 
Fast Blue (•), ENK-immunoreactive (o) and double-labeled (*) cells 
after Fast Blue injections into the PB. 
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Figure 8. Line drawings of coronal sections through four levels of the 
hypothalamus (A-D, rostral to caudal) illustrating the distributions of 
Fast Blue (•), DYN-immunoreactive (o) and double-labeled (*) cells 
after Fast Blue injections into the PB. 
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Figure 9. Line drawings of coronal sections through four levels of the 
hypothalamus (A-D, rostral to caudal) illustrating the distributions of 
Fast Blue (•), AII-immunoreactive (0) and double-labeled(*) cells 
after Fast Blue injections into the PB. 
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Figure 10. Line drawings of coronal sections through four levels of 
the hypothalamus (A-D, rostral to caudal) illustrating the 
distributions of Fast Blue (•), NT-immunoreactive (o) and 
double-labeled (*) cells after Fast Blue injections into the PB. 
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Figure 11. Line drawings of coronal sections through four levels of 
the hypothalamus (A-D, rostral to caudal) illustrating the 
distributions of Fast Blue (•), CRF-immunoreactive (o) and 
double-labeled (*) cells after Fast Blue injections into the PB. 
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Figure 12. Line drawings of coronal sections through four levels of 
the hypothalamus (A-D, rostral to caudal) illustrating the 
distributions of Fast Blue (e), GAL-immunoreactive (o) and 
double-labeled (*) cells after Fast Blue injections into the PB. 
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Figure 13. Line drawings of coronal sections through four levels of 
the hypothalamus (A-D, rostral to caudal) illustrating the 
distributions of Fast Blue(•), SS-immunoreactive (o) and 
double-labeled (*) cells after Fast Blue injections into the PB. 
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Figure 14. Line drawings of coronal sections through two levels of the 
paraventricular hypothalamus {A-B, rostral to caudal) illustrating the 
distributions of Fast Blue (•), OXY-immunoreactive (o) and 
double-labeled (*) cells after Fast Blue injections into the PB. 
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Figure 15. Line drawings of coronal sections through two levels of the 
paraventricular hypothalamus {A-B, rostral to caudal) illustrating the 
distributions of Fast Blue (e), AVP-immunoreactive {o) and 
double-labeled (*) cells after Fast Blue injections into the PB. 
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Figure 16. Line drawings of coronal sections through four levels of 
the hypothalamus (A-D, rostral to caudal) illustrating the 
distributions of Fast Blue (e), MSH-like immunoreactive (o) and 
double-labeled (*) cells after Fast Blue injections into the PB. 
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Figure 17. Line drawings of coronal sections through four levels of 
the hypothalamus (A-D, rostral to caudal) illustrating the 
distributions of Fast Blue (e), ACTH-immunoreactive (o) and 
double-labeled (*) cells after Fast Blue injections into the PB. 
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CHAPTER VI 
GENERAL DISCUSSION 
Descending pathways to the PB. Previously, a limited number of 
immunohistochemical studies had examined the forebrain projections to 
the PB for their neuropeptide content (Swanson, '77; Saper et al., '85; 
Milner and Pickel, 1 86a,b). The results from the present dissertation 
demonstrate that many neuropeptide-immunoreactive neurons in the 
amygdala, BST and hypothalamus project to the PB (Table l). In the 
first two experiments, the PB afferent cell populations in the BST and 
CeA were found to stain for identical neuropeptides, that is, for CRF, 
NT and SS but not for ENK. Both of these peptidergic projections arise 
from largely circumscribed areas within the CeA and lateral BST, 
namely, the lateral subdivision of the CeA and the dorsal lateral 
subnucleus of the BST; and, both projections terminate predominantly in 
the external lateral subnucleus in the caudal half of the PB. 
In the third experiment, the PB afferent cell populations in the 
hypothalamus were found to stain for a wide variety of neuropeptides, 
and each of these cell populations was found to contain a unique 
neuropeptide composition. Furthermore, the hypothalamic peptidergic 
projections to the PB were found to terminate predominantly in the 
rostral half of the PB. The neuropeptide-immunoreactive neurons in the 
hypothalamus that project to the PB are most numerous in the lateral 
hypothalamus (particularly in the perifornical area), the parvocellular 
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subdivisions of the PVH, the retrochiasmatic area and the arcuate 
nucleus. In a recent study examining the peptide content of 
hypothalamic pathways to the spinal cord using similar antisera, a 
different neuropeptide composition was found (Cechetto and Saper, '88), 
suggesting that peptidergic differences may, in addition to 
topographical differences, distinguish the hypothalamic descending 
pathways. 
Historically, anterograde studies of the descending projections to 
the PB have reported diffuse labeling within the PB, suggesting a lack 
of topographical organization in the forebrain afferents (e.g., Conrad 
and Pfaff, '76; Hopkins and Holstege, '78; Swanson and Cowan, '79; 
Saper et al., '79). Contrary to this view, the results from this 
dissertation suggest that the forebrain afferents of the PB are 
topographically organized, although these data await further 
confirmation. For example, both the lateral CeA and dorsal lateral BST 
project almost exclusively to the external lateral PB subnucleus; in 
contrast, the medial CeA and posterior lateral BST project to a number 
of PB subnuclei, including the medial, central lateral and external 
lateral subnuclei (Chapters III, IV). These results further 
demonstrate the close anatomical ties between the CeA and lateral BST; 
in particular, the dorsal lateral BST may be homologous to the lateral 
CeA, and the posterior lateral BST, to the medial CeA. 
Some degree of topographical organization within the hypothalamic 
projection to the PB was also observed (Chapter V). For example, 
retrogradely labeled cells in the caudal LH were most numerous after 
injections into the caudal waist area of the PB, while these same 
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injections produced few labeled cells in perifornical ~H. Conversely, 
labeled cells in perifornical LH were more numerous, and cells in 
caudal LH less common, after rostral lateral PB injections. 
Possible significance of neuropeptides. Neuropeptides are 
particularly abundant in autonomic structures such as the hypothalamus, 
CeA, BST, PB, NTS and midbrain central gray (for review, Pickel, '86). 
Possibly, neuropeptides may play a role in the visceral responses 
elicited from these autonomic nuclei. As evidence, relatively 'large' 
microinjections (i.e., 1-10 nanomoles) of neuropeptides, when 
bilaterally placed in autonomic nuclei, produce a variety of visceral 
effects. For example, microinjections of CCK into the NTS of awake 
cats produce an increase in respiratory frequency and a decrease in 
tidal volume (Denavit-Saubie et al., '85). Injections of NT into the 
CeA of rats increase their nociceptive threshold (Kalivas et al., '82). 
At physiological doses (i.e., picomoles), microiontophoresis of 
neuropeptides causes a variety of neuronal effects; these effects are 
dependent on the neuropeptide and its site of application within the 
CNS (Nicoll et al., '77; Henry, '82; Eberly et al., '83; Siggins et 
al., '85). 
Few studies have specifically examined the role of neuropeptides 
in the PB. In one study, the application of the opioid agonists, 
FK-33824 and DADLE, to the rostral dorsal surface of the pons caused a 
significant decrease in respiratory frequency; this effect was 
attributed to opioid diffusion to the medial PB (Hurle et al., '85). 
More conclusively, Denavit-Saubie et al ('78) found that opioid 
agonists depress the spontaneous firing activity of respiratory-related 
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neurons in the medial PB. Clearly, more studies are needed Q~rvre any 
conclusions can be drawn as to the role of neuropeptides in the PB. 
Directions for future research. There are a number of possible 
experiments that would elucidate the role of these descending pathways, 
and their intrinsic neuropeptides, in central autonomic regulation. At 
a gross level, one could microinject (i.e., 10-6 H concentrations) 
bilaterally the neuropeptides examined here into the PB, and then 
observe what visceral responses (e.g., respiratory, cardiovascular) are 
elicited. The results from this study would suggest what PB visceral 
functions are associated with what neuropeptides. In addition, one 
could bilaterally inject neuropeptide antibodies into the PB to 
determine whether depletion of these neuropeptides produces any 
visceral effects. 
At the cellular level, it would be interesting to inject 
"physiological .. doses (Le., picomoles) of the neuropeptides present in 
PB afferents, and then record single units in the PB for their 
responses (e.g., excitatory, inhibitory, biphasic). By marking the 
recording site, one could determine whether neurons in different PB 
subnuclei respond differently to a given neuropeptide. 
Role of PB in visceral control. Early studies of the PB noted its 
importance as a relay for visceral afferent information from the NTS to 
the forebrain (Norgren and Leonard, '71,'73; Norgren, '74, '76; Saper 
and Loewy, 1 80). Recently, investigators have found that afferent 
information from different visceral organs converges onto individual PB 
neurons (Ogawa et al., '82; Hermann and Rogers, '85), suggesting that 
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the PB may 'integrate' diverse visceral sensory information rather than 
merely 'relay' that information to the forebrain. 
As indicated in Chapter 1, physiological studies have implicated 
the PB in a diversity of visceral functions. As other central 
autonomic nuclei are also involved in these functions, what functions 
of the PB are unique? The position of the PB between, and its 
extensive connections with, autonomic nuclei in both forebrain and 
lower brainstem/spinal cord suggests a pivotal role for the PB in 
central autonomic regulation (Saper, '82). This role may involve 
adding both flexibility and safety to the central autonomic system. 
Specifically, the PB receives a heavier forebrain input than the NTS; 
thus, it could buffer the critical medullary reflexes from excess 
forebrain interference. At the same time, the PB projects heavily to a 
number of brainstem nuclei, including cranial motor nuclei and the 
reticular formation; these projections may provide a greater range of 
visceral responses and behaviors than could be found in a system 
without a nucleus at this level. 
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Table 1. Neuropeptide Immunoreactivity Detected in 
Afferent Cell Populations of the Parabrachial Nucleus. 
Afferent NeuroEeEtide 
CRF NT SS DYN ENK GAL AU aMSH ACTH AVP OXY 
CeA ++ ++ ++ + nc nc nc nc nc 
BST ++ ++ ++ + nc nc nc nc 
LH +++ +++ + +++ +++ +++ +++ nc nc nc 
RCh + + + + + ++ ++ nc nc 
PVH + + + + + + + nc nc + + 
ARC + + +++ +++ nc nc 
nc No cell staining in this nucleus 
No double-labeled cells found with this antisera 
+ Less than 4% of afferent cell population stains for this an tisera 
++ 5-14% 
+++ 15-30% 
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